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ABSTRACT 
Maarit Kauppi 
Determinants of bone strength and predictors of hip fracture among Finnish adults. 
Results from the Health 2000 Survey and the Mini-Finland Health Survey 
 
University of Turku, Faculty of Medicine, Department of Clinical Medicine, Internal 
Medicine; Doctoral Programme of Clinical Investigation, University of Turku; National 
Institute for Health and Welfare, Turku, Finland. Annales Universitatis Turkuensis. 
Medica – Odontologica, Turku, Finland 2015. 
The objective of this thesis was to identify the determinants of bone strength and 
predictors of hip fracture in representative samples of Finnish adults. A secondary 
objective was to construct a simple multifactorial model for hip fracture prediction over 
a 10-year follow-up period. 
The study was based on the Health 2000 Survey conducted during 2000 to 2001 (men 
and women aged 30 years or over, n=6 035) and the Mini-Finland Health Survey 
conducted during 1978 to 1980 (women aged 45 years or over, n=2 039). Study subjects 
participated in health interviews and comprehensive health examination. In the Health 
2000 Survey, bone strength was assessed by means of calcaneal quantitative ultrasound 
(QUS). The follow-up information about hip fractures was drawn from the National 
Hospital Discharge Register.  
In this study, age, weight, height, serum 25-hydroxyvitamin D (S-25(OH)D), physical 
activity, smoking and alcohol consumption as well as menopause and eventual HRT in 
women were found to be associated with calcaneal broadband ultrasound attenuation 
(BUA) and speed of sound (SOS). Parity was associated with a decreased risk of hip 
fracture in postmenopausal women. Age, height, weight or waist circumference, 
quantitative ultrasound index (QUI), S-25(OH)D and fall-related factors, such as 
maximal walking speed, Parkinson’s disease, and the number of prescribed CNS active 
medication were significant independent predictors of hip fracture. At the population 
level, the incremental value of QUS appeared to be minor in hip fracture prediction when 
the fall-related risk factors were taken into account.  
A simple multifactorial model for hip fracture prediction presented in this study was 
based on readily available factors (age, gender, height, waist circumference, and fall-
related factors). Prospective studies are needed to test this model in patient-based study 
populations. 
Keywords: calcaneal quantitative ultrasound, QUI, S-25(OH)D, fall risk, maximal 
walking speed, hip fracture, risk assessment, elderly 
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TIIVISTELMÄ 
Maarit Kauppi  
Luun lujuutta määrittävät ja lonkkamurtumia ennustavat tekijät suomalaisilla 
aikuisilla. Tuloksia Terveys 2000- ja Mini-Suomi -terveystutkimuksista  
 
Turun yliopisto, lääketieteellinen tiedekunta, kliininen laitos, sisätautioppi; Turun 
yliopiston kliininen tohtoriohjelma; Terveyden ja hyvinvoinnin laitos, Turku, Finland. 
Annales Universitatis Turkuensis. Medica – Odontologica, Turku, Finland 2015. 
Tämän väitöskirjan tavoitteena oli tunnistaa luun lujuutta määrittäviä ja 
lonkkamurtumien ilmaantuvuutta ennustavia tekijöitä suomalaisia aikuisia edustavissa 
aineistoissa. Lisäksi tavoitteena oli muodostaa yksinkertainen malli, jolla voitaisiin 
ennustaa lonkkamurtumia yli 10 vuoden seurantajakson aikana.  
Väitöstutkimus koostui kahdesta suomalaista aikuisväestöä edustavasta aineistosta, 
Terveys 2000 –tutkimukseen vuosina 2000-2001 osallistuneista 30 vuotta täyttäneistä 
miehistä ja naisista (n=6 035) sekä Mini-Suomi –terveystutkimukseen vuosina 1978-
1980 osallistuneista 45 vuotta täyttäneistä naisista (n=2 039). Tutkittavien terveyttä ja 
toimintakykyä selvitettiin terveyshaastatteluiden ja monipuolisen terveystarkastuksen 
avulla. Terveys 2000 –tutkimukseen osallistuneilta henkilöiltä arvioitiin luun lujuutta 
kantaluun ultraäänimittauksen (QUS) avulla. Tiedot seurannan aikaisista 
lonkkamurtumista saatiin valtakunnallisesta HILMO-rekisteristä.  
Tutkimuksessa todettiin, että ikä, paino, pituus, seerumin 25-hydroksi-D-vitamiini (S-
25(OH)D), fyysinen aktiivisuus, tupakointi ja alkoholin käyttö sekä menopaussi ja 
mahdollisen hormonikorvaushoidon kesto naisilla olivat yhteydessä ultraäänen 
vaimentumaan (BUA) ja nopeuteen (SOS) kantaluussa. Synnyttäneisyys oli yhteydessä 
pienempään lonkkamurtumariskiin postmenopausaalisilla naisilla. Ikä, pituus, paino tai 
vyötärön ympärys, kantaluun ultraääni-indeksi (QUI), S-25(OH)D sekä 
kaatumisalttiuteen liittyvät tekijät, kuten maksimaalinen kävelynopeus, Parkinsonin 
tauti ja keskushermostoon vaikuttavien lääkkeiden lukumäärä olivat lonkkamurtumia 
itsenäisesti ennustavia tekijöitä. Kun kaatumisen riskitekijät otettiin huomioon, 
kantaluun ultraäänimittaus toi väestötasolla lonkkamurtumariskin ennustamiseen vain 
vähäistä lisäarvoa.  
Tässä tutkimuksessa esitetty yksinkertainen malli lonkkamurtumariskin arvioimiseksi 
perustui helposti saatavilla oleviin tekijöihin (ikä, sukupuoli, pituus, vyötärön ympärys, 
maksimaalinen kävelynopeus, Parkinsonin tauti, keskushermostoon vaikuttavien 
lääkkeiden lukumäärä). Mallin toimivuutta tulisi arvioida potilasaineistoihin 
perustuvissa pitkittäistutkimuksissa. 
Avainsanat: kantaluun ultraäänimittaus, QUI, S-25(OH)D, kaatumisalttius, 
maksimaalinen kävelynopeus, lonkkamurtuma, riskin arviointi, ikääntyneet 
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1 INTRODUCTION 
Fragility fractures constitute a serious health problem in elderly populations, 
worldwide. Hip fractures, in particular, commonly result in excess mortality, 
impaired functional capacity and substantial health care costs [1-4]. In Finland, 
about 7 000 hip fractures occur annually. Some 6 000 of these are first hip 
fractures [5]. The risk of hip fracture increases with age in both genders. Over 95 
percent of the victims are 50 years or older [6]. Women are more likely to sustain 
a hip fracture and the female to male incidence ratio appears to be about two to 
one [4,7]. 
The risk of fragility hip fracture varies widely among countries. The annual 
age-adjusted incidence of hip fracture has recently been reported to range from 58 
to 574 fractures per 100 000 persons among women and from 35 to 290 fractures 
per 100 000 persons among men [8]. Incidence rates reported from the 
Scandinavian countries are among the highest. According to statistics from 2003 
to 2008 on Finnish subjects aged 50 years or older the annual incidence of the first 
hip fracture was 470 fractures per 100 000 persons among women and 250 
fractures per 100 000 persons among men [9]. 
The average age at the occurrence of hip fracture has increased over time. In 
Finland, a mean age of a hip fracture patient increased by seven years in women 
and by six years in men between the years 1970 and 2010 [10]. The age-adjusted 
incidence of hip fracture appears to be increasing in some countries, but levelling 
off or declining in others [4,10-13]. Nevertheless, even if the incidence declines, 
the number of hip fractures is likely to grow as a result of an increasing life 
expectancy and a larger number of elderly people in society [14,15].  
Appropriate information on all major risk factors of hip fractures is essential 
for proper identification of subjects with a particularly high fracture risk and to 
refer these for a comprehensive clinical assessment and to receive preventive 
measures and care as required. 
Bone mass (and therefore bone strength or fragility) is largely determined by 
heredity and a number of factors including age, various lifestyle factors such as 
nutrition, physical activity, smoking and alcohol consumption and by chronic 
disease conditions and medications [16]. Bone loss substantially accelerates in 
women as they pass the menopause [17]. Such factors, so-called clinical risk 
factors (CRF), can be used for the assessment of fracture risk. Bone mineral 
density measurements by means of dual energy X-ray absorptiometry (DXA) can 
serve the same purpose. Combinations of risk factors and density measurements 
are likely to improve the risk assessments [18]. 
Most hip fractures occur as a consequence of a fall [19]. One third of subjects 
aged 65 or over, and more than half of those aged 80 or over fall yearly [20,21]. 
Factors associated with poor mobility, impaired balance and poor vision 
predispose one to falls and therefore ultimately also to fractures [19,22-24]. 
Introduction 
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Several risk factors increase fracture risk both by decreasing bone strength and 
increasing liability to fall. Typical examples of such factors include age, female 
gender, vitamin D deficiency, heavy alcohol intake, physical inactivity and certain 
diseases and medications [19,22,23]. 
Guidelines by the World Health Organization (WHO) and International 
Osteoporosis Foundation (IOF) propose that assessments of future fracture risk 
should be based on a 10-year probability of fracture [25]. Supported by the WHO, 
the Fracture Risk Assessment Tool (FRAX) has been developed for this purpose 
[26]. FRAX is based on age, gender, weight, height, smoking, alcohol intake, 
rheumatoid arthritis, use of systemic glucocorticoid therapy and a number of other 
potential causes of secondary osteoporosis. FRAX can be used with or without 
bone mineral density measurement. However, liability to fall is not taken into 
account by FRAX. Even if this algorithm may identify subjects at increased risk 
of fracture and help in clinical decisions, it is so far not known whether its 
application indeed will be able to prevent major fractures, such as hip fractures in 
Finnish men and women. 
The majority of studies on the determinants and predictors of hip fractures have 
been carried out in women. In addition, the study populations of such studies have 
rarely been strictly representative of the general population and the follow-up 
periods have generally been rather short. We have had the opportunity to 
investigate these aspects of hip fracture in two rather large nationally 
representative study populations with fairly long follow-up periods.  
In a nationwide survey covering large numbers of subjects living in dispersed 
and remote localities bone strength can hardly be expected to be assessed by 
means of DXA. Instead, quantitative calcaneal ultrasound (QUS) suits well for 
this purpose. The device is transportable and does not involve ionizing radiation, 
and above all, QUS has been shown to predict hip fractures comparably to DXA 
[27-29]. 
Prospective studies assessing calcaneal QUS together with clinical risk factors 
for hip fracture prediction are scarce [30]. Moreover, the impact of single risk 
factors or such factors in various combinations on the variation in hip fracture risk 
is uncertain. It seemed therefore pertinent to investigate the determinants of bone 
strength and the predictors of hip fracture by means of QUS in representative 
samples of Finnish men and women and, in particular, to construct a simple model 
for hip fracture prediction based on a limited number of readily available risk 
factors in a follow-up study extending up to 10 years. 
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2 REVIEW OF THE LITERATURE 
The literature review of the present academic dissertation was based on searches 
performed through Medline database using search terms of relevant issues, such 
as bone physiology, determinants and measurement techniques of bone strength, 
osteoporosis, hip fracture incidence and risk factors of hip fracture. These searches 
were supplemented by manually reviewing bibliographies of eligible studies and 
relevant review articles. However, no systematic literature review was performed. 
The quality grading of the literature was based on an author’s subjective 
assessment rather than on use of any quality assessment instruments [31].  
 Bone strength 
 Bone structure and physiology 
The human skeleton consists of over 200 bones. They provide a rigid framework 
for locomotion that supports the body and maintains its shape. In addition, it 
protects vital organs and participates in mineral homeostasis. The skeleton is also 
a primary site of hemopoiesis [32].  
Bones are made of proteins (mainly collagen) that are impregnated with 
crystals of calcium hydroxyapatite. This composite structure gives bone its 
contradictory properties of stiffness yet flexibility and lightness yet strength. The 
relative proportions of protein and mineral vary across anatomic sites according 
to the function a given bone usually performs [33]. 
According to their shapes bones can be divided into long (e.g., femur), short 
(e.g., tarsal bones), flat (e.g., hip bone, sternum) or irregular bones (e.g., vertebras) 
[32]. The outer layer of bone is composed of cortical (compact) bone, which is 
solid and dense. Cortical bone has an outer periosteal surface and inner endosteal 
surface. The interior of bone is filled with trabecular (cancellous) bone that is a 
spongelike network of plates and rods. The structure of trabecular bone makes the 
overall bone structure lighter and allows room for the blood vessels and marrow. 
Trabecular bone has also a much greater surface area and is metabolically more 
active than cortical bone. The relative proportion of cortical and trabecular bone 
is 80 to 20 percent of the total bone mass but varies greatly among different bones. 
For example, the proportion of trabecular bone ranges from 70 percent to 90 
percent in vertebral bodies and in the heel and less than 10 percent in the midshafts 
of long bones such as the femoral shaft and radius. The neck of femur is 25 percent 
of trabecular bone, whereas the intertrochanteric region is about 50 percent to 75 
percent trabecular bone [34].  
Cortical and trabecular bone is normally formed in a lamellar way such that 
collagen fibrils are laid down in alternating orientations. This kind of structure 
Review of the literature 
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gives lamellar bone its significant strength. In nonlamellar or woven bone the 
collagen fibrils are laid down in a disorganized manner, and therefore woven bone 
is weaker than lamellar bone. Woven bone is formed during the formation of 
primary bone and may also be seen in some pathologic conditions [32]. 
Bone is a dynamic tissue and is constantly undergoing a change in response to 
environmental stimuli. These changes are performed throughout life in adaptive 
processes of modelling and remodelling. The cells engaged in these processes are 
osteoblasts (bone forming cells) and osteoclasts (bone resorbing cells), which 
compose bone multicellular units (BMU) [32]. Osteocytes (“bone maintainers”) 
are involved in the remodelling process; e.g., by functioning as mechanosensory 
cells that sense and signal the need for adaptive processes [35]. They also 
comprise most of all bone cells in adult bone, and are the longest lived bone cells. 
In bone modelling, new bone is formed by osteoblasts without prior bone 
resorption. This process predominates during childhood and adolescence, and 
enables longitudinal and radial growth of bones as well as their adaptations in 
shape in response to physiologic stimuli and mechanical forces. During bone 
remodeling, bone formation is preceded by bone resorption performed by 
osteoclasts. By this process bone is renewed in order to maintain its strength and 
mineral homeostasis [32,36-38]. 
Normally, bone remodeling is balanced and only little changes in the total 
amount of bone occur. This is regulated by various physiologic and biomechanical 
factors. Systemic hormones (such as parathyroid hormone (PTH), calcitonin, 
thyroid hormone, insulin, growth hormone (GH), insulin-like growth factor-1 
(IGF-1) hormone, cortisone and sex hormones), cytokines, vitamins and minerals 
as well as mechanical loading have important regulatory roles [32]. Estrogen has 
an antiresorptive effect on bone by reducing osteoclastic activity, but also an 
anabolic effect by increasing the proliferation, differentiation and function of 
osteoblasts. Androgens play an important role in bone formation. Testosterone is 
likely to have an anabolic effect on bone formation by itself, but has also 
beneficial effects on bone by its conversion to estrogen [17].  PTH together with 
vitamin D has a role in regulating of calcium homeostasis, and already very small 
decreases in serum calcium stimulate the secretion of parathyroid hormone, which 
in turn releases calcium in the circulation [34].  
 Age-related changes  
During growth, the balance between the volume of bone being resorbed and 
formed in the BMU is positive and leads to the addition of bone in each 
remodeling event. After the longitudinal growth has ceased bone mass and density 
continues to increase until the twenties or early thirties when the peak bone mass 
is achieved. Peak bone mass is largely (60-80%) determined by genetic factors, 
but also other factors, such as physical activity and nutrition play an important 
role during the growth [38]. After reaching the peak bone mass the remodelling 
rate decreases. When age advances, the amount of bone formed in each BMU, in 
Review of the literature 
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each site remodeled declines. This is likely to result in net bone loss especially in 
perimenopausal and postmenopausal phases when, due to estrogen deficiency, 
bone remodeling rate increases in women.  Also, in men bone remodelling is likely 
to increase slightly along with increasing age [39]. An increased remodelling rate 
leads to trabecular thinning (predominant in men) and disconnection of trabeculae 
(predominant in women), cortical thinning and porosity [40]. During their 
lifespans, women lose about 50 percent of their trabecular bone and 30 percent of 
their cortical bone. Corresponding figures for men are 30 percent and 20 percent, 
respectively [41]. Achieving the highest possible peak bone mass during the 
growth period is important in order to maintain sufficient bone mass to withstand 
these changes. Age-related bone loss is partly compensated by concurrent 
periosteal apposition. Even though this periosteal apposition does not increase the 
total amount of bone, it increases the bending resistance by enlarging the diameter 
of the bone as well as by redistributing bone tissue further from the central axis of 
the bone [39,40]. However, as a consequence of all age-related changes in bone 
material and structural properties, aging bones’ ability to absorb energy when 
loaded decreases and bones become more fragile and susceptible to fracture.  
 Osteoporosis 
A WHO study group defined osteoporosis as: “a systemic skeletal disease 
characterized by low bone mass and microarchitectural deterioration of bone 
tissue with a consequent increase in bone fragility and susceptibility to fracture” 
[42]. According to a more recent definition from the NIH Consensus Development 
Panel on Osteoporosis, osteoporosis is: “a skeletal disorder characterized by 
compromised bone strength predisposing to an increased risk of fracture” [43]. 
Operationally osteoporosis is defined on the basis of a BMD measurement. 
According to the WHO criteria, osteoporosis is defined as: “a BMD that lies 2.5 
SDs or more below the average value for young healthy women (a T-score of ≤ 
-2.5)” [42].  A T-score between -1 and -2.5 is thought to refer to osteopenia and a 
T-score of -1 or higher is considered as normal. T-score values of BMD were 
originally used in epidemiological studies to enable comparison among 
populations. It was only later when T-score values were applied to diagnostics of 
osteoporosis in clinical practice. Currently, the NHANES III female reference 
data is recommended to be used for T-score derivation occurring at the hip region 
for both women and men [44].  
Osteoporosis is traditionally classified into primary and secondary 
osteoporosis [45]. Primary osteoporosis is thought to be related to the aging 
process, and can occur in both genders. However, it is often associated with 
hypogonadism that especially women experience after the menopause. Therefore, 
this condition is more common in women than in men (by a ratio of about 6 to 1). 
In secondary osteoporosis, the loss of bone mass results from a disease, 
medication or certain lifestyle factors. Important causes of secondary osteoporosis 
include: long-term use of systemic glucocorticoids, heavy alcohol use, smoking, 
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gastrointestinal disease, such as inflammatory bowel disease and celiac disease, 
hyperthyroidism, hyperparathyroidism and hypercalciuria. Also, diabetes and 
rheumatoid arthritis may result in osteoporosis [46,47].  
 Assessment of bone strength 
Bone strength is determined by bone quantity; i.e., the amount of bone bulk, but 
also by structural and material properties of bone. Material properties include 
factors associated with bone mineral content and density, collagen composition as 
well as the number, size and localization of microdamage. Structural properties 
involve bone geometry and bone microarchitecture such as trabecular 
architecture, cortical thickness and porosity [33,48]. In clinical practice, bone 
strength is usually assessed by means of dual energy X-ray absorptiometry 
(DXA), quantitative computed tomography (QCT) and quantitative ultrasound 
(QUS) measurements. 
 
DXA 
BMD measured by means of dual energy X-ray absorptiometry (DXA) is regarded 
as the method of choice in diagnosing osteoporosis [44].  DXA can be used to 
assess both axial (e.g., proximal femur and lumbar spine) and appendicular 
skeleton (e.g., radius and calcaneus). It can also be used to assess bone mineral 
content of the whole skeleton [49,50]. The first generation of DXA scanners (e.g., 
Hologic QDR-1000 and Lunar DPX) used a pencil beam X-ray, whereas new 
generation systems (e.g., Hologic QDR-4500 and Lunar Expert-XL) use a fan-
shaped X-ray beam. Because the X-ray has both high- and low-photon energies, 
two different types of tissue (mineralized and soft tissue) can be distinguished. 
Thus, a direct measurement of BMD without interference from soft tissue is 
possible. The result is an areal (g/cm²) and not a volumetric (g/cm³) BMD. This 
may lead to overestimation of BMD in large bones [49]. The accuracy of the DXA 
measurements for bone mineral content has been reported to be three to eight 
percent [51] and the precision (CV=coefficient of variation) is 0.6 to 1.9 percent 
[52,53]. The radiation dose for DXA measurement depends on device, 
measurement site and the scan mode used. The effective dose is generally low, 
ranging from 0.07 µSv used in peripheral scans with a pencil beam DXA [54] and 
up to nearly 60 µSv used in vertebral scan with fan-beam DXA [49,50]. 
BMD measured by means of DXA is assumed to account for 60 to 80 percent 
of bone strength. However, clinical implementation of BMD measurement has not 
been unproblematic. There are biological variations in the composition of bone. 
Differences also exist between the measurement techniques of DXA. Therefore 
T-scores measured at different sites and with different techniques are not 
commensurable [44]. The femoral neck is used as a reference site for the DXA 
measurement because of its high predictive value of hip fracture in many 
prospective studies [55,56]. There is a substantial overlap in BMD values among 
subjects who sustain a hip fracture and those who do not. DXA thus appears to be 
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predictive of hip fracture rather at the population than at the individual level 
[57,58].  
 
QUS 
Quantitative ultrasound measurement is based on mechanical ultrasound waves 
(frequency range from 20 kHz to 100 MHz) that pass through bone and cause bone 
material to vibrate on a micro-scale. This in turn, alters the shape, intensity and 
speed of a propagating wave [59]. Based on this, bone tissue can be characterized 
in terms of speed of sound (SOS, m/s) and broadband ultrasound attenuation 
(BUA, dB/MHz). In addition to SOS and BUA composite variables, such as 
stiffness index (SI) and quantitative ultrasound index (QUI) have been introduced. 
These variables are linearly weighted averages of SOS and BUA [60].  
There are many different quantitative ultrasound devices on the market. 
Ultrasound devices can be divided into water-coupled (wet) or gel-coupled (dry) 
systems. Examples of wet systems are Achilles+ (Lunar Corp; Madison, WI, 
USA) and UBA 575+ (Walker Sonix Inc., Worcester, MA, USA), which is no 
longer available, provides a background for current systems. Dry systems include 
CUBA Clinical (McCue Plc; Winchester, UK) and Sahara Clinical Bone 
Sonometry (Hologic Inc., Bedford, MA, USA). The measurement sites may differ 
between the devices. However, in the clinical setting the most widely used 
quantitative ultrasound measurement site is calcaneus [61,62]. One reason for this 
is that calcaneus is mostly composed of trabecular bone, which is metabolically 
more active than cortical bone, and is thus more sensitive to the changes in bone 
density and structure. In addition, calcaneus is a weight-bearing bone having two 
nearly plane-parallel sides and is covered only by thin soft-tissue layers, which 
makes the measurement easier [63]. The short-term precision (CV) of QUS ranges 
between 2.5 to 6.0 percent for BUA, 3.1 to 5.5 percent for SOS and 3.3 to 3.5 
percent for QUI [64,65]. 
Previous studies have shown QUS values to correlate reasonably well with 
BMD measured by means of DXA, the strongest associations being found in site-
specific measurements (e.g., calcaneus) [66]. However, according to previous 
meta-analysis, QUI has been shown to have relatively low sensitivity and 
specificity as for identifying individuals determined osteoporotic by DXA 
measurement [67]. For example, at QUI T-score threshold level of -1.5, the 
summary estimate of sensitivity was 66% (95% CI=53-77 %) and the specificity 
was 74% (95% CI=66-81%). This may arise from the fact that these two techiques 
partly measure different properties of the bone. In addition to bone mineral 
density, QUS is influenced by structural properties of the bone. For example, QUS 
values differ depending on the orientation of the bone sample being measured, 
which suggests that QUS values mirror mechanical anisotropy of the bone. In 
addition, QUS has been shown to correlate with structural parameters measured 
by histomorphometry [63,68,69].  
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Although QUS is not a diagnostic method of osteoporosis comparable to dual 
energy X-ray absorptiometry, it has other assets. It is portable, less expensive than 
DXA and free of ionizing radiation. QUS has been shown to discriminate between 
the subjects with and without fractures, and to predict hip and other fragility 
fractures equally well as DXA [27-29,64,65,70,71]. However, the information 
about hip fracture prediction with QUS in men is rather scarce [29,72,73]. 
 
QCT 
Quantitative computed tomography (QCT) uses a calibration standard to convert 
Hounsfield Units (HU) of the conventional CT image to bone mineral density 
values. It may be used to assess bone mineral density both in axial spine 
(multidetector CT) and in appendicular skeleton; e.g., forearm, tibia and calcaneus 
(high-resolution peripheral quantitative CT) [50,74,75]. Compared to other 
techniques, the main advantage in QCT measurement is its ability to measure true 
volumetric BMD (g/cm³). Thus, the result is not size-dependent. With QCT, it is 
also possible to assess trabecular and cortical bone separately. Moreover, it 
enables an assessment of bone microstructure [75,76]. The short-term precision 
(CV) of spinal, hip and peripheral QCT range between 0.9 to 4 percent. The in 
vivo accuracy lies between four to 15 percent. Radiation exposure of QCT 
protocols vary depending on the imaging site and technique used. The effective 
doses for multidetector CT measurements are of the order of <0.01-2.6 mSv, 
whereas approximate effective doses for high-resolution peripheral QCT scans 
may be as low as <0.005 mSv [50,75,77]. 
There is evidence that spinal QCT can be used to make decisions about the 
initiation of treatment, and it is also useful in monitoring changes in BMD over 
time and the response to treatment. In women, spinal and peripheral QCT 
measurements predict vertebral and hip fractures, respectively. However, 
evidence of such prediction is lacking in men. In addition, further prospective 
studies are needed to assess the ability of spinal QCT to predict hip fractures in 
both men and women [75,77]. One of the limitations of QCT is its relatively high 
radiation exposure compared to, for example, DXA. In addition, accessibility of 
general CT scanners is limited. Also, the reference data for QCT, particularly in 
men and children, are few. Therefore, QCT has been mainly used as a research 
tool and its clinical use has thus far been limited [77]. 
 Hip fractures 
 Diagnosis and classification 
Diagnosis of hip fracture is based on a clinical X-ray examination. Hip fractures 
can be classified into two main groups: intracapsular or femoral neck fractures 
and extracapsular fractures [78]. Extracapsular fractures include pertrochanteric 
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and subtrochanteric fractures. Figure 1 shows the locations and diagnostic codes 
(ICD-10) of these fractures of the proximal femur [79]. In Finland, the ICD-10 
codes have been used since year 1996 following the ICD-8 and ICD-9 codes that 
were used during the years: 1987 to 1995 [80]. These codes are reported in the 
National Hospital Discharge Register. This register has been shown to be a 
reliable and accurate source of information about hospital admissions and 
discharges. The coverage with respect to hip fractures has been reported to be 98 
percent [81,82].  
 Classification and diagnostic codes (ICD-10) of fractures in the 
proximal femur (adapted and modified from previous report [9]). 
 Risk factors 
The risk of hip fracture is determined not only by bone fragility but also by non-
skeletal or fall-related factors, including those associated with the fall event, such 
as the impact force and hardness of landing surface [40,83]. Many of the risk 
factors interact in a complex manner and may be defined as multifactorial risk 
factors [19]. Figure 2 summarizes the most well-recognized risk factors of hip 
fracture related to bone-strength, fall risk or both. 
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 Risk factors of hip fracture. Adapted and modified from previous 
reports [16,19,22-24,40,83-86]. 
Bone strength-related risk factors 
Bone strength is determined by its material properties, such as mineral content 
and density, and the structural properties, such as bone geometry and 
microarchitecture of bone [33,48]. BMD is the surrogate measure of bone strength 
most often assessed in clinical practice. Prospective studies have shown that at the 
population level, each SD reduction in femoral neck BMD measured with DXA 
approximately doubles the risk for hip or other osteoporotic fractures [55,56]. 
Similar increments in risk have been found for one SD reductions in calcaneal 
QUS variables assessed by different ultrasound devices. For example, the 
gradients of risk (RR/SD) of hip fracture have been estimated to be 1.69 and 1.96 
 
Bone strength-related risk 
factors 
 Low BMD 
 Bone geometry and 
microarchitecture 
 Low body weight 
 Tallness 
 Low calcium intake 
 High sodium intake 
 Smoking 
 Systemic corticosteroids 
 Hyperparathyreoidism 
 Hyperthyroidism 
 Gastrointestinal disease 
(inflammatory bowel 
disease, celiac disease) 
 Hypogonadism, early 
menopause 
 Hereditary factors 
 
Multifactorial risk factors 
 Old age 
 Female gender 
 Vitamin D deficiency 
 High alcohol intake 
 Physical inactivity 
 Muscle weakness 
 Anticonvulsants 
 Rheumatoid arthritis 
 Diabetes 
 Hypertension 
 Previous fracture 
 
Fall-related risk factors 
 Balance deficit 
 Walking problems 
 Dizziness, postural 
hypotension 
 History of falls 
 Impaired vision 
 CNS active medication 
 Polypharmacy 
 Parkinson’s disease 
 Stroke 
 
Fall event 
 Impact force 
 Hardness of landing surface 
HIP FRACTURE
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for BUA and SOS, respectively [30]. QUS variables have also been suggested to 
measure some structural and qualitative properties in addition to BMD [63,68,69]. 
Excessive weight loss has been found to be harmful for bone health, and is 
associated with an increased risk of hip fracture especially in thin subjects [87,88]. 
An inverse association between body weight and hip fracture risk has been 
established in several prospective studies [89-92]. This is likely to be associated 
with a lower bone mineral density in subjects with low body mass, but it may also 
reflect underlying chronic conditions. In addition, an increased risk of hip fracture 
in these subjects may partly result from thinner fat padding protecting the hip in 
the occasion of a fall [93]. However, the association between body weight and 
fracture risk appears to be non-linear. Leanness is a risk factor of fracture rather 
than obesity as a protective factor [94]. Obesity may protect against some 
fractures, such as hip fractures, but be a risk factor for others (for example, ankle 
and humeral fractures) [95]. Also tallness has been found to be a predictor of hip 
fracture in several previous studies [19,23,92,96]. The increased risk of hip 
fracture in taller subjects is presumably a consequence of biomechanical factors, 
such as hip axis length (HAL) [23,97]. Hip fracture risk increases by 1.6– to 1.9–
fold for each SD increase in HAL above the mean of the control population [97]. 
In addition, the femoral neck-shaft angle, femoral neck width and upper femoral 
neck area as geometrical characteristics may contribute to hip fracture risk [98]. 
Also, a greater impact during a fall may increase the risk of fracture in taller 
subjects compared to shorter subjects. 
  An adequate intake of calcium is an important factor for normal growth and 
development of the skeleton [99]. Calcium supplementation may increase bone 
mass during the growth period [100] and decrease bone loss in premenopausal 
women [101]. However, the results about the association between calcium 
supplementation and bone strength or fracture risk later in life are less clear-cut. 
Most of previous prospective cohort studies and RCTs have found no significant 
association between calcium supplementation alone and hip fracture risk, and 
even adverse effects have been reported [102-104]. It is likely that when the intake 
of calcium is at a sufficient level, supplementation may have only little effect on 
fracture risk. On the other hand, in order to obtain significant reductions in fracture 
risk, an adequate supply of vitamin D along with calcium may be needed, and the 
benefit of supplementation is likely to be evident mostly among subjects deficient 
of these nutrients [105]. According to previous evidence, a calcium intake of 1200 
mg/d in combination with vitamin D (cholecalciferol) doses of 800 IU/d would 
reduce the hip fracture risk in elderly institutionalized women who are deficient 
in calcium and vitamin D [106,107]. 
High sodium intake increases calcium excretion in urine. This, in turn, may 
accelerate bone loss and osteoporosis [108]. A longitudinal study on 
postmenopausal women has shown that halving the sodium intake was associated 
with a significantly reduced rate of bone loss [109]. However, it is not known how 
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much this contributes to fracture risk because studies assessing sodium intake and 
fracture risk are lacking. 
Active smoking has been established to be a significant risk factor for future 
hip fracture in several prospective cohort studies [91,92,110,111]. Lower BMD in 
smokers compared to non-smokers explains a part of a higher fracture risk. 
However, there are BMD-independent factors that contribute to fracture risk. 
These potentially include certain lifestyle factors related to smoking habit, such 
as low physical activity, that may increase the risk of falls. In addition, smoking 
may induce changes in microarchitecture of bone not captured by BMD 
measurement [112]. 
Long-term systemic glucocorticoid use is an important risk factor for 
secondary osteoporosis and hip fracture. The association between glucocorticoid 
use and bone loss or fracture risk has been shown to be dose-dependent with more 
pronounced effects seen with daily doses of at least five mg (of prednisolone or 
equivalent) [113,114]. Other chronic conditions associated with decreased bone 
strength and increased hip fracture risk include hyperparathyroidism [115], 
gastrointestinal diseases, such as inflammatory bowel disease [116], untreated 
celiac disease [117] and hyperthyroidism [118]. 
Estrogen deficiency is mainly responsible for the age-related bone loss in 
postmenopausal women but also in older men [17]. Amenorrhea related to 
endocrine abnormalities (e.g., anorexia nervosa, athletic amenorrhea) and early 
menopause as well as a short fertile period increases the risk of osteoporotic 
fractures [119-121]. On the other hand, HRT may prevent adverse effects of 
menopause on the skeleton and decrease fracture risk in postmenopausal women 
[122,123]. The previously found association between increased parity and 
decreased risk of hip fracture [124,125] is likely to reflect beneficial effects of 
longer estrogen exposure period on bone structure and strength. 
The risk of hip and other osteoporotic fracture is higher among those whose 
parent has suffered a hip fracture [126-128]. Heritable factors, including genetic 
and environmental factors have been estimated to determine 50 to 85 percent of 
the variance in BMD depending of the skeletal site [126,127]. In addition, there is 
a heritable contribution from femoral neck geometry [129], regulation of bone 
remodelling, S-25(OH)D and PTH concentrations [130,131], age at menopause 
[132] and muscle strength [133], all of which are likely to contribute to bone 
fragility and hip fracture risk. 
 
Fall-related risk factors 
Falls are common among older subjects. One third of people aged 65 years or 
older and over half of those aged 80 years or older fall every year [20,21]. 
Although only a few percent of these falls lead to fracture, most of hip fractures 
occur as a consequence of the fall [19]. Impaired neuromuscular functions, such 
as decreased muscle strength, walking difficulties and impaired balance are 
among the most important predictors of falls and fractures [24,128,134-137]. 
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Walking speed is a good indicator of muscle strength, balance and other 
sensorimotor functions [138,139]. There are different test protocols to measure 
walking speed. The most often used distances are 2.4 meters [140,141], 4 meters 
[142,143] and 6.0 or 6.1 meters [135,144]. Also, a 10-meter walking course has 
often been used in Finland [145,146]. Either usual or maximal walking speed can 
be measured [147,148]. There is no established optimal threshold value of walking 
speed for fracture prediction but a usual walking speed of 1.0 m/s have been used 
to predict several future adverse health outcomes in elderly subjects [147]. 
Chronic conditions such as Parkinson’s disease or stroke affect postural control 
and balance through neuromuscular or sensory decline, and are likely to increase 
risk of falls and hip fractures [23,149]. Similarly, certain central nervous system 
active (CNS) medication, especially benzodiazepines, antidepressants and 
antipsychotics have been shown to be independently associated with increased 
risk of falls and fractures in older subjects [85,150-156]. Polypharmacy with such 
medications, in particular, has been shown to be harmful [86,151]. In addition, 
dizziness or postural hypotension [157,158], prior history of falls [159-161] and 
impaired vision [162-164] have been shown to be associated with increased risk 
of falls, injurious accidents and hip fractures. 
 
Multifactorial risk factors 
Many risk factors for hip fracture act through decreasing bone strength and quality 
as well as by increasing liability to fall. Age is one example of this kind of 
multifactorial risk factor. The risk of hip fracture has been estimated to increase 
13-fold between the ages of 60 and 80. Only a four-fold increase of this can be 
explained by decreases in bone mineral density [9]. The rest is associated with 
increased liability to fall, and perhaps with other age-related aspects of health and 
functional capacity that are not necessarily captured by routine measurements. 
Most of hip fractures occur in postmenopausal women. This arises partly from 
the postmenopausal estrogen deficit, which predisposes to an increased risk of 
bone fragility. Also, peak bone mass and size attained during the growth period 
remains smaller in women compared to men, thus leaving women with less 
reserve to withstand age-related losses in bone strength [17]. In addition, the 
incidence of falls and fall-related injuries in old age has is higher among women 
compared to men [165]. 
An adequate supply of vitamin D from diet or from the synthesis in the skin is 
essential for preserving calcium homeostasis and bone health. Vitamin D 
(cholecalciferol, D3 and ergocalciferol, D2) is metabolized by the liver to 25-
hydroxyvitamin D (S-25(OH)D) and subsequently in the kidneys to its active 
form, 1,25-dihydroxyvitamin D (1,25(OH)2D). The production of this active form 
of vitamin D is regulated by plasma parathyroid hormone (PTH) and serum 
calcium and phosphorus levels [166,167]. S-25(OH)D is usually used to 
determine a subject’s vitamin D status. Although there is no consensus on optimal 
levels of serum 25-hydroxyvitamin D, concentrations between 50 and 80 nmol/l 
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have been suggested to be sufficient with regard to bone health [167,168]. This is 
based on S-25(OH)D concentrations at which measured PTH levels begin to level 
off [169,170]. 
In addition to its actions on bone, vitamin D is proposed to have beneficial 
effects on muscle strength, balance control and physical function [171]. These 
effects, in turn, are likely to decrease the risk of falling and fracture. However, the 
results concerning the association of BMD and hip fracture risk with vitamin D 
status have been inconsistent [172-179]. Case-control studies and cohort studies 
have often found lower levels of S-25(OH)D in hip fracture cases compared to 
controls or inverse relation between vitamin D status and fracture risk. 
Randomized controlled trials (RCT), however, have often showed no significant 
difference in BMD or hip fracture risk between those randomised to 
supplementation and controls [172,177]. There is growing evidence that vitamin 
D supplementation would be more efficient in reducing hip fracture risk if 
combined with calcium [105,176,178,180]. Vitamin D supplementation appears 
to be beneficial for bone health mainly among those with low S-25(OH)D levels 
[181]. In women, the relationship between S-25(OH)D and fracture risk has been 
suggested to be dependent on race or ethnicity. In white women, a significant 
negative association between S-25(OH)D and fracture risk has been found, 
whereas  no significant association or even higher fracture risk in higher S-
25(OH)D values have been reported in Black, Asian, Hispanic or Native 
American women [182]. 
Alcohol abuse is detrimental for bone health [183,184]. It may increase the risk 
of falls and is associated with increased fracture risk [92,156,185,186]. In contrast, 
several studies have found moderate alcohol use to be associated with higher bone 
density [187-189], and the results on the association between moderate alcohol 
use and hip fracture risk are controversial [22,186,190,191]. 
Many prospective cohort studies have shown an inverse association between 
physical activity and hip fracture risk in men and women [92,111,192-195]. 
Physical inactivity tends to be associated with reduced bone strength [196,197], 
muscle strength and motor coordination [198], all of which are likely to increase 
fracture risk. Raising the level of physical activity during the lifespan has been 
found to be associated with a decreased fracture risk [194,199]. Similarly, 
decreasing the level of physical activity increases hip fracture risk later in life 
[200].  
The association between physical activity and fracture risk may be confounded 
by health status and the genetic inheritance of qualification for a physically active 
lifestyle [195]. Subjects with a better health and muscular function are more likely 
to choose a physically active lifestyle. Yet, some previous studies have found a 
beneficial effect of leisure-time physical activity with respect to hip fracture risk 
even independently of health status and function [192,200]. However, because 
there is a lack of randomized controlled trials evaluating the causality between 
Review of the literature 
 
24 
 
physical activity and hip fractures, the potential confounding cannot be ruled out 
[195,201].  
Handgrip strength is a good indicator of overall muscle strength and also 
predicts physical disability and mobility limitation [202,203]. In addition, 
maintenance of handgrip strength over perimenopausal transition appears to be 
associated with lower bone loss [204], and low handgrip strength predicts hip 
fractures in elderly men and women [135,205]. Mechanical loading that muscle 
induces on an adjacent bone has an important role in determining bone mass and 
strength [206]. Moreover, appendicular muscle mass correlates with bone cortical 
thickness also at sites not adjacent to mechanical loading [207]. This finding 
suggests that there are some additional paracrine and endocrine interactions 
between bone and muscle tissue by which they coordinate their masses [208]. 
The use of antiepileptic drugs, such as phenytoin, phenobarbital and 
carbamazepin associate with an accelerated rate of bone loss and consequent bone 
fragility [209,210]. In addition, prospective studies show an increased risk of falls 
and hip fractures among postmenopausal women and elderly men using 
antiepileptic drugs independent of BMD [152,211]. 
The increased risk of fractures that are related to rheumatoid arthritis (RA) 
[212,213] is partly attributed to the effects of glucocorticoid treatment. However, 
an increased fracture risk exists also in RA patients not using oral glucocorticoids. 
RA is associated with joint inflammation, consequent joint destruction and 
periarticular bone loss. In addition, chronic systemic inflammation in RA may 
result in increased risk of systemic bone loss [212,214]. Also, nonsteroidal anti-
inflammatory drugs (NSAID), commonly used to treat RA, may contribute to 
fracture risk [215,216]. Moreover, RA is associated with an increased risk of 
falling, which is at least partly due to joint pain, impaired muscle strength, fatigue, 
postural instability and consequently reduced functioning [217-220]. 
Subjects with type 1 diabetes have generally decreased BMD, whereas those 
with type 2 diabetes have often normal or high BMD [221]. However, the risk of 
hip fracture has been found to be higher in subjects with either type 1 or type 2 
diabetes, compared to subjects without this disease [23,128,221,222]. It is 
suggested that hyperglycemia, elevated oxidative stress and hypercysteinemia, 
which are often associated with diabetes, may disturb collagen cross-link 
formation that impair bone properties independently of BMD [223]. Also, 
peripheral neuropathy, a common complication associated with long-lasting 
diabetes, is likely to increase risk of falling and risk of fracture [224]. 
Hypertension associates with increased calcium excretion in urine and 
consequent bone mineral loss in some [225,226] but not in all [227,228] studies. 
Large case-control and prospective studies have found a higher risk for hip and 
other osteoporotic fractures in hypertensive subjects [84,229,230]. A recent study 
based on the Dubbo Osteoporosis Epidemiology Study proposed the association 
between hypertension and fracture risk to be independent of BMD [231]. 
Hypertension may damage brain structures controlling gait control and balance, 
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which in turn may predispose to falls [232,233] and consequent fractures. 
However, more information is needed about the association of hypertension and 
hip fracture risk. For example, the contribution of antihypertensive medication to 
this association is inconclusive. Certain groups of antihypertensive drugs, such as 
thiazide diuretics and beta-blockers, increase BMD and decrease the risk of hip 
fractures [234,235]. On the other hand, some studies have found negative 
[236,237] or no association [238,239] between antihypertensives and bone 
strength. An increased risk of falling and fall-related injuries among users of 
antihypertensive drugs demonstarted in some studies [152,153,240] is likely to be 
due to the acute effects of medication on postural blood pressure causing 
orthostatic hypotension. On the other hand, antihypertensive medication may 
decrease the risk of fall in the long run by improving blood pressure control and 
preventing orthostatic hypotension [241]. However, the role of individual classes 
of hypertensive medication with respect to fall risk has not been explicitly 
determined [240].   
Several earlier studies have shown previous fragility fracture to be a significant 
predictor of future osteoporotic fractures, including hip fractures 
[22,128,159,160,242,243]. A minor part of this association has been explained by 
low BMD the proportion of which has been shown to decrease with age. The 
mechanism for the BMD-independent increase in fracture risk is not fully 
understood but is likely to be associated with coexisting morbidity increasing the 
risk of fall [160,242]. 
 Prediction of hip fracture 
Because several independent risk factors for hip fracture have been identified, the 
challenge is to develop methods for accurate identification of subjects at increased 
risk for hip fracture who might benefit from preventive or therapeutic measures. 
For this, it is essential to determine those factors and combinations of them which 
contribute the most to the risk. Measures of bone strength and fall-related factors 
have independent effects on fracture risk, and combining such factors and other 
so-called clinical risk factors (CRF) improves the detection of subjects at 
increased risk of various fragility fractures, including hip fractures 
[24,144,159,160,244]. Within a given level of BMD, women with a greater 
number of clinical risk factors are at increased risk of sustaining a hip fracture. 
Correspondingly, within a category of number of CRF, lower BMD has been 
found to be associated with higher rates of hip fracture [128]. 
The World Health Organization (WHO) and the International Osteoporosis 
Foundation (IOF) have recommended that the risk of fracture should be expressed 
as a short-term absolute risk (for example, 10-years) [25]. Assessment tools using 
this approach have been established, of which the WHO Fracture Risk Assessment 
Tool (FRAX) [26], QFracture algorithm [245] and Garvan Fracture Risk 
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Calculator [246] are supposedly the most commonly used tools for assessing 
fracture risk. Table 1 shows a summary of these fracture risk assessment tools. 
The FRAX algorithm, developed in conjunction with the World Health 
Organization, was published in 2008. It calculates the 10-year probability of hip 
and other major osteoporotic fractures, such as spine, wrist and humerus [18], and 
can be applied to subjects aged 40 to 90 years. The FRAX tool is available online 
as well as in simplified paper version. The model of FRAX is based on data of a 
series of meta-analyses derived from nine population-based cohorts from around 
the world, and has been validated in 11 independent cohorts [244]. Variables 
included in the FRAX algorithm are age, weight, height, and dichotomized risk 
factors, such as prior fragility fracture, parental history of hip fracture, current 
tobacco smoking, the use of long-term glucocorticoids, rheumatoid arthritis, 
alcohol consumption and other causes of secondary osteoporosis, such as type I 
diabetes, osteogenesis imperfecta, untreated long-standing hyperthyroidism, 
hypogonadism or premature menopause (<45 years), chronic malnutrition or 
malabsorption and chronic liver disease. The algorithm can be used either with or 
without BMD measurement (femoral neck). Both risk of fracture and risk of death 
are taken into account while computing the fracture probability [26]. 
FRAX has been criticized for it does not take into account the risk of falling or 
variables, such as vitamin D status or calcium deficiency in fracture prediction. It 
also lacks a dose-response relationship for alleged risk factors, such as use of 
glucocorticoids, smoking or alcohol intake, and does not take into account racial 
and ethnic differences that may influence the risk [247-249]. In addition, the 
cohorts, are not truly representative of the general populations. For instance, 
practically all of the subjects in the validation cohorts have been women [244]. 
However, some recent studies have suggested a similar ability of FRAX to predict 
hip fractures in men compared to women [250,251]. 
QFracture algorithm, first published in 2009, was designed to estimate an 
absolute risk of osteoporotic fracture and hip fracture in primary care [252]. This 
algorithm is based on a large database of routinely collected data from 357 general 
practices in the United Kingdom (2 357 895 patients aged 30-85 in the 
development cohort) and is validated by data from 178 practices (1 275 917 
patients aged 30-85 in the validation cohort). The QFracture algorithm allows 
fracture risk estimation from one to 10 years in subjects aged 30 to 99 years. 
Variables used are readily available in patients’ healthcare records or that patients 
themselves probably know without the need for clinical measurements or 
laboratory tests. These include age, gender, BMI, smoking, alcohol use, history of 
falls, parental history of osteoporotic fracture, type 2 diabetes, cardiovascular 
disease, asthma, cancer, rheumatoid arthritis, chronic liver or kidney disease, 
gastrointestinal malabsorption, use of tricyclic antidepressants or corticosteroids, 
use of HRT and endocrine disorders. QFracture was updated in 2012 when further 
developments were performed according to the recommendations made by the 
National Institute for Health and Clinical Excellence (NICE). These included 
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extending the age range to patients older than 85 years and including additional 
variables such as previous fragility fracture, ethnic group, epilepsy and use of 
anticonvulsants, care home residency, additional inflammatory arthropaties, 
chronic obstructive airway disease, type 1 diabetes, Parkinson’s disease and 
dementia. There were 3 142 673 patients in the development cohort and 1 583 373 
patients in the validation cohort of the updated algorithm. The updated algorithm 
has been shown to explain 71.7% of the variation in hip fracture risk in women 
and 70.4 percent in men [245]. It thus shows improved performance compared to 
the 2009 algorithm. Compared to FRAX, QFracture is at least as effective in 
identifying patients with an increased risk for hip fracture [252].  
The Garvan Fracture Risk Calculator was developed in 2007 using data 
collected in the Dubbo Osteoporosis Epidemiology Study conducted by the Bone 
and Mineral Research Program of Sydney's Garvan Institute of Medical Research 
[246]. The Garvan Fracture Risk Calculator integrates the femoral neck BMD T-
score information with four clinical risk factors; i.e., age, gender, number of falls 
in the past year and number of fractures since age 50 years. This tool allows 5- 
and 10-year probability calculation for hip and other types of fractures, including 
for example spine, wrist, humerus, pelvis, rib, sternum and distal femur. Elderly 
subjects, aged 60 to 96 years can be assessed. The Garvan tool has shown 
moderate and similar discriminative ability compared to FRAX tool both in older 
men and women [253-255]. However, because the number of risk factors included 
in the Garvan tool is limited, it may underestimate fracture risk in patients with 
many clinical risk factors. Another limitation of this tool is that it is available only 
for subjects aged 60 years or older. In addition, it is based only on the Australian 
population [256].
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The development and validation cohorts of these fracture risk assessment tools 
as well as study populations of previous prospective studies assessing bone 
strength together with clinical risk factors for hip fracture prediction have rarely 
been representative of the general population. The majority of these studies have 
been carried out in women. Table 2 summarizes the characteristics and main 
results of the prospective studies assessing bone strength combined with clinical 
risk factors for prediction of hip fracture. Some of these studies had relatively 
large study populations. The number of participants ranged between 225 and 
12064. However, none of these studies were based on a truly representative 
sample of the general population. Only four of these studies included also men in 
their study populations [72,73,135,243]. The mean follow-up times ranged from 
33 months up to 14 years, but extended over five years only in seven studies 
[128,135,137,243,257-259]. Eight of the studies assessed QUS for its prediction 
of hip fracture [72,73,137,144,159-161,257]. Six of these studies 
[137,144,159,160,257,259] included fall-related risk factors, such as walking 
speed and muscle strength in the final analyses. Only two prospective studies used 
the Sahara device as a QUS measurement method [137,161]. One study [243] 
estimated the proportion of hip fractures that may have been hypothetically 
reduced by elimination of certain risk factors. According to this analysis, 
approximately 57 percent of hip fracture cases in women and 37 percent in men 
were attributable to the presence of low BMD, postural instability and/or 
quadriceps weakness, a history of falls and prior fracture. None of these studies 
assessed how much of the variation in hip fracture risk could be explained by 
single risk factors or different combinations of them. 
Against this background, it seemed necessary to study the determinants of bone 
strength assessed by means of QUS, and the predictors of hip fracture in 
representative samples of the Finnish adult population. In particular, it seemed 
pertinent to construct a simple model for hip fracture prediction based on a limited 
number of readily available risk factors in a follow-up study extending up to 10 
years. 
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, d
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 p
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r c
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 m
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 b
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 m
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 b
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 c
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, c
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, c
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w
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r t
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t r
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 c
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f f
ra
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 c
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 m
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, t
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 C
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 C
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. f
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3 AIMS OF THE STUDY 
The objective of this study was to identify determinants of bone strength and 
predictors of hip fracture in representative samples of Finnish adults. 
 
The specific aims were: 
 
1. To identify determinants of the estimated bone strength assessed by means 
of calcaneal quantitative ultrasound  
2. To determine the bone strength-related risk factors of hip fracture  
3. To ascertain the fall-related risk factors of hip fracture  
4. To construct a simple multifactorial model for hip fracture prediction 
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4 STUDY POPULATIONS AND METHODS 
 Study populations 
 Studies I, III and IV 
Studies I, III and IV were based on the Health 2000 Survey, a comprehensive 
nationwide health survey conducted in Finland during 2000-2001 (Figures 3 and 
5) [260]. A stratified two-stage cluster sample comprised subjects aged 30 years 
or over living in mainland Finland (community and institutions). The study frame 
was regionally stratified according to five university hospital regions, each with 
approximately one million habitants. From each of these university hospital 
regions 16 health care districts were sampled as clusters (80 health center districts 
out of the total of 249 districts in mainland Finland). The 15 largest health center 
districts in the country were all selected in the sample with probability of 1, and 
the remaining 65 health center districts by systematic probability proportional to 
the size method. From these 80 health center districts a sample of 8 028 persons 
was selected by systematic random sampling (Figure 3). In order to include a 
sufficient number of elderly persons, subjects aged 80 or over were oversampled 
(2:1) relative to their proportion in the population.  
The structured health interview elicited information about participants’ health 
status, illnesses, use of health care services, functional capacity, health behavioral 
factors and sociodemographic factors. The participation rate of the health 
interview was 87% (n=6 986) of the original study sample. A comprehensive 
health examination performed in a health center after the health interview included 
assessment of functional capacity, symptom interview and clinical examinations 
performed by a physician. Measurements of blood pressure, heart rate, resting 
ECG, basic anthropometrics and heel bone quantitative ultrasound were 
performed. Also, fasting blood samples for serum glucose and 25-hydroxyvitamin 
D analyses were taken. The participation rate of the comprehensive health 
examination was 79% (n=6 354). Questionnaires elicited information about 
different aspects of subjects’ functional capacity, quality of life, common 
symptoms, leisure time activities, lifestyle factors, living environment, 
psychological experiences and job perceptions. A detailed description of the study 
design, data collection methods and health and functional status of population of 
this health Survey has been reported elsewhere [260].   
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 Study II 
Study II was based on the Mini-Finland Health Examination Survey, which was a 
comprehensive health survey implemented during 1978-1980 (Figures 4 and 6) 
[261]. The study population was a stratified two-stage cluster sample drawn from 
the national population register to represent Finnish adults aged 30 years or older. 
Firstly, forty representative strata were selected out of clusters of one or more 
neighboring municipalities. One cluster was then picked at random to represent 
each stratum. Secondly, a sample of 8 000 subjects (3 637 men and 4 363 women) 
was randomly drawn from the population register by systematic sampling (Figure 
4).  
The study included a health interview, which elicited information about 
participants’ health, functional capacity, medications, use of health care services 
and aspects of health behavior. Altogether 7 703 subjects (over 96% of the whole 
sample) participated in the health interview. A basic health examination was 
carried out 1-6 weeks after the interview and included interviews on symptoms, 
several examinations, such as blood pressure and pulse measurements, ECG and 
spirometry. Also, blood and urine samples were taken and a joint function test 
evaluating musculoskeletal impairment was performed. Altogether 7 217 subjects 
(90% of the whole sample) participated in the health examination. Details of the 
study design and implementation of  this health survey has been reported 
elsewhere [261]. 
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The Health 2000 Survey and the Mini-Finland Health Survey were both conducted 
in accordance with the ethical principles of the Declaration of Helsinki [262]. The 
Health 2000 Survey was approved by the Ethics Committee for epidemiology and 
public health in the hospital district of Helsinki and Uusimaa, Finland. All 
participants gave their written informed consent. The flow of studies (I, III, IV) 
based on the Health 2000 data is shown in Figure 5. The flow of study II, based 
on the Mini-Finland survey, is shown in Figure 6. The data and the inclusion 
criteria used in the original publications are shown in Table 3. 
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 A flowchart for studies I, III and IV based on the Health 2000 
data.
 
 
 
 
 
 
 
 
  
The Health 2000 
population sample, 
n=8028 
Subjects who participated 
in the health examination 
proper, n=6354 
Subjects aged 30 years or 
older for whom the 
information on QUS and 
S-25(OH)D was available, 
n=6035 
Subjects aged 50 years or 
older for whom information 
on QUS and S-25(OH)D 
was available, n=3325 
Subjects aged 55 years or 
older for whom information 
on QUS, S-25(OH)D, 
walking speed and handgrip 
strength was available, 
n=2324
Subjects with 
incident high-
energy hip fracture 
(n=20) excluded 
Subjects with 
previous hip 
fracture (n=19) or 
incident high-
energy hip fracture 
(n=9) excluded 
Subjects included 
in study I, n=6035 
(75 % of  those 
within this age 
range in the  
original sample)  
Subjects included 
in study IV, 
n=2300 (80 % of  
those within this 
age range in the  
original sample) 
Subjects included 
in study III, 
n=3305 (75 % of  
those within this 
age range in the  
original sample) 
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 A flowchart for study II based on the Mini-Finland survey. 
 
The Mini-Finland 
population sample, 
n=8000 (4363 women) 
Subjects who participated 
in the health interview, 
n=7703 
Women who participated 
in the basic health 
examination, n=3895 
Women aged 45 years or 
older for whom the 
information on parity and 
age at the last menstrual 
period was available, 
n=2039
Women with previous hip 
fracture excluded, n=2028 
(80 % of those within this 
age range in the original 
sample) 
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 Methods 
Hip fractures (Studies II, III and IV) 
The follow-up information about hip fractures was drawn from the National 
Hospital Discharge Register, which has been shown to be an accurate and reliable 
source of information with 98% coverage and 98% sensitivity with respect to hip 
fracture diagnoses [82]. The patients admitted to the hospital for primary 
treatment of hip fractures (Studies III and IV: codes 72.0-72.2 as primary or 
secondary diagnoses according to ICD-10; Study II: code 820 according to ICD-
8 and ICD-9) were identified. High-energy fractures; i.e., those following falls 
exceeding one meter from one level to another or traffic accidents or causalities 
alike were defined according to the external cause codes from the Hospital 
Discharge Register and were excluded (Studies III and IV). 
 
QUS (Studies I, III and IV) 
Quantitative ultrasound measurements were performed by trained examination 
nurses. A Hologic Sahara device (Hologic Bedford, MA, USA) was used to record 
broadband ultrasound attenuation (BUA, dB/MHz) and speed of sound (SOS, m/s) 
transmitted in a medio-lateral direction across the calcaneum. Both SOS and BUA 
are higher in healthy than in osteoporotic calcaneal bone. The measurement was 
performed on the right foot except in case of two repeated error messages, in 
which case re-measurement was performed on the left foot. A Sahara device was 
always kept at room temperature when used, and temperature changes did not pose 
problems in connection with transits to different examination locations. There 
were five devices, one for each of the five districts. Each of them was checked for 
performance quality daily before the first participant using the phantom provided 
by the manufacturer. Other quality measures used to monitor the quality of the 
examination included repeat and parallel measurements on field team staff, on 
subjects in same examination group and parallel measurements between groups 
(ten voluntary participants). The reliability coefficient for repeat measurements 
(n=193) covering all field teams was 0.91 for BUA and 0.92 for SOS. The QUS 
values were compared with BMD measured by DXA (Norland XR-26) in 105 
volunteers with bone densities distributed throughout the clinical relevant range 
[263]. The correlation coefficients ranged for SOS from 0.53 (with BMD at the 
femoral neck) to 0.57 (with BMD at the lumbar spine) and for BUA from 0.46 
and 0.56, respectively (p<0.0001 for all correlations). Furthermore, a strong 
correlation (r=0.72) was found between calcaneal BUA and bone mineral density 
(BMD) measured by peripheral DXA (PIXI) at the same site [66]. A composite 
variable, the quantitative ultrasound index (QUI) [264], was calculated from the 
values of BUA and SOS. 
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S-25(OH)D (Studies I-IV) 
Venous blood samples were taken from arm vein after a minimum four hour 
fasting. The serum specimens were immediately (no later than 90 min from 
sampling) frozen to -20˚C on site. The samples were transferred from the field 
storage points to final storage in boxes packed in dry ice no later than 1-2 weeks 
after sampling. For the final storage, the samples were kept in -20˚C (the Mini-
Finland) or -70˚C (the Health 2000) until analysed and were protected from light 
when processed. S-25(OH)D was measured by radioimmunoassay (the Health 
2000: Incstar, Stillwater, MN, USA/ the Mini-Finland: Diasorin). In the Health 
2000 Survey (studies I, III, and IV) the intra-assay coefficient of variation (CV) 
was 3.5% and the interassay CV was 6.9% at the concentration of 36 nmol/l. The 
limit of detection was 3.8 nmol/l. In the Mini-Finland survey (study II) the 
interassay coefficient of variation was 7.8% at the mean level of 47.3 nmol/l 
(n=167) and 9.12% at the level of 131.3 nmol/l (n=135). 
 
Anthropometry and body composition (Studies I-IV) 
Weight and height were measured with light clothing without shoes, height to the 
nearest 0.5 cm and weight to the nearest 0.1 kg. Body mass index (BMI) was 
calculated as weight (kg) divided by the square of height (m²). Waist 
circumference was determined as the mid-point between the lowest rib and the 
iliac crest. Circumference measurements were recorded to an accuracy of 0.5 cm. 
Body fat was estimated (in kilograms and percentage) with an impedance meter 
(InBody 3.0, Biospace Seoul, Korea). This instrument measured the resistance of 
the arms, trunk and legs at frequencies 5, 50, 250, and 500 kHz and makes use of 
eight tactile electrodes of which two are in contact with the palm and thumb of 
each hand and two with the anterior and posterior aspects of the sole of each foot. 
 
Smoking, alcohol consumption and physical activity (Studies I-IV) 
Smoking reported in a health interview was classified into three categories: never-
smokers, former smokers (those who had quit smoking at least one month prior to 
the survey) and current smokers (studies I, III and IV). In Study II, the category 
of current smokers was further classified into current smokers of cigars, pipe or 
fewer than 20 cigarettes a day, and current smokers of 20 cigarettes or more a day.   
Alcohol use was estimated on the basis of the reported average consumption 
during the past month and expressed as absolute ethanol in grams/week (g/wk). 
In studies I and III, this was classified into the following three categories: no use, 
moderate use and heavy use. The limit of heavy use was set at 280 g/wk in men 
and 140 g/wk in women [265]. In study II, alcohol use was classified into four 
categories: no use, use of 1-49, 50-249 and >249 g/wk, respectively. In study IV, 
the following classification was used: no use, use of 1-84 g/wk and use of >84 
g/wk. The limit of 84 g/wk was based on the guidelines used in Italy and in the 
United States recommending no more than 7 units of alcohol per week for elderly 
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men and women [266]. This limit has also been suggested by the Finnish Ministry 
of Social Affairs and Health. 
A questionnaire elicited information on leisure-time physical activity that was 
classified into three categories: active (regular physical activity, for example 
jogging, cycling or swimming), moderately active (physical activity along with 
other activities, for example, fishing or gardening) and sedentary (no actual 
physical activity). 
 
Walking speed (Study IV) 
Walking speed was measured with a stopwatch over a distance of 6.1 meters 
[267]. Subjects were asked to walk the distance as quickly as they could, starting 
from their normal, standing posture behind the start line and continuing at full 
speed beyond the end line. Walking aids were allowed when necessary. The 
reliability of this test was good (intraclass correlation coefficient, ICC=0.77, 
n=163) [268]. 
 
Handgrip strength (Study IV) 
Handgrip strength was measured in Newtons from the dominant hand with a hand-
held dynamometer (Good Strength, IGS01, Metitur Oy, Jyväskylä). The subjects 
were asked to grip the handle as hard as possible for 3-5 seconds. The test was 
repeated after 30 seconds and the maximum result was recorded. If the difference 
between the two measurements was greater than 10%, a third test was done again 
30 seconds later. Intraclass correlation coefficient of this test was 0.95 (n=265) 
[268]. 
 
Chronic conditions (Study IV) 
Information on Parkinson’s disease and stroke was based on the structured sets of 
questions and on the diagnostic assessments by the field physicians in connection 
with the clinical examination. In addition, information drawn from the National 
Hospital Discharge register was used to assess the occurrence of stroke [268]. 
Subjects were considered hypertensive if they were entitled to special 
reimbursement for hypertension medication, had a mean systolic blood pressure 
≥140 mmHg or mean diastolic blood pressure ≥90mmHg or had been diagnosed 
with hypertension and were receiving antihypertensive medication. Subjects were 
considered to have diabetes if their fasting plasma glucose level was ≥7.0 nmol/l 
or if they were using insulin or oral antidiabetic medication. 
 
CNS active medication and liability to fall (Study IV) 
Faintness or dizziness as recent symptoms were inquired about and classified into 
one of the following three categories: not at all, quite little and to some extent or 
more. The number of falls during the previous 12 months while walking was 
classified into two categories: 0-1 and 2 or more falls. Reported information about 
central nervous system (CNS) active medication (such as opioids, anticonvulsants, 
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antipsychotics, anxiolytics, hypnotics and sedatives, antidepressants or 
psycholeptics and psychoanaleptics in combination) was classified into one of 
three categories according to the number of such drugs in current use: 0, 1-2 and 
3 or more drugs. 
 
Self-rated health and level of education (Study II)  
Self-rated health was classified according to a three-point scale: good, moderate 
or poor. The level of education (Study II) was classified according to the total 
years of education as follows: <8 years (less than primary school), 8-12 years 
(primary school plus lower or higher level secondary education) and >12 years 
(higher education, mostly studies or degrees at university level). 
 
Reproductive history and use of hormone replacement therapy (HRT) (Studies I 
and II) 
Women were asked about their reproductive history and were considered 
postmenopausal after an absence of menses for 12 months. Years since 
menopause were calculated from the last (physiological) menstruation onwards. 
The use and eventual years of HRT were also asked about. The number of children 
was asked about, and parity was classified into three categories: nulliparous (no 
births), parous with one to two births and parous with three or more births. 
 
Follow-up (Studies II, III and IV) 
In Study II, the follow-up period started at the beginning of 1978 and continued 
until the end of year 1994, until the hospitalisation due to the first hip fracture, or 
until the date of death, whichever came first. Mean follow-up period was 13 years 
(26 200 person-years). In Studies III and IV the follow-up period started at the 
beginning of 2000 and continued until the end of follow-up period, until the 
hospitalization due to a hip fracture or until the date of death, whichever came 
first. In Study III, the follow-up period continued until the end of 2009, and 
resulted in a mean follow-up period of 8.4 years (27 757 person-years). In Study 
IV, the follow-up period continued until the end of 2011, with a mean follow-up 
of 9.8 years (22 540 person-years). 
 Statistical methods 
All statistical analyses were performed with the SAS software (version 9.1/9.3; 
SAS Institute Inc., Cary, NC, USA) and SUDAAN, which takes into account the 
sampling design including the oversampling of those aged 80 years or over 
(Research Triangle Institute, Release 10.0.1). Data of baseline characteristics of 
the study population are reported as mean values (SD/SE) and/or percentages. A 
p value of less than 0.05 was considered statistically significant.  
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Study I 
Pearson’s correlation was calculated between the QUS (BUA and SOS) variables 
and determinants of bone fragility. The analysis of covariance was used to 
compare the age-adjusted ultrasound results according to smoking status, alcohol 
use and physical activity. Multiple linear regression analysis was performed in 
order to assess independent roles of S-25(OH)D, age, measures of body built, 
lifestyle factors and menopausal status in women as determinant of QUS 
variables. 
 
Study II 
Cross-sectional associations between the alleged risk factors of hip fracture and 
parity were analyzed with multivariate logistic regression. Cox’s proportional 
hazards models were used to estimate the strength of association between parity 
and the risk of hip fracture during the follow-up. The full model excluding the 
first 5 or 10 years of follow-up from the analysis was also performed in order to 
explore the stability of the proportional hazards.  
 
Studies III and IV 
Comparisons between men and women and between subjects with and without an 
incident hip fracture were performed using Student’s t test for continuous 
variables and chi-square test for categorical variables. Cox’s proportional hazards 
models were used to estimate predictors of hip fracture. Adjusted hazard ratios 
(HR) with 95% confidence intervals (CI) were calculated. For continuous 
variables, HRs were computed for an increment of one standard deviation (SD). 
Only factors that proved significant predictors of hip fracture in the gender and 
age adjusted models were included in the fully adjusted model. The predictive 
power of the models including various combinations of risk factors was further 
assessed by means of coefficients of determination (R²) [269]. In Study IV, 
alongside with the R2 assessments, the net reclassification improvement (NRI) 
method [270] was used to quantify the changes in classification of subjects to low 
or high risk categories of fracture risk after additions of different variables to the 
model. A 3% fracture risk was used as a threshold for these risk categories. This 
threshold is the 10-year hip fracture probability above which the treatment of 
osteoporosis is suggested to become cost-effective in the USA according to the 
National Osteoporosis Foundation (NOF) Guide Committee [271]. 
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5 RESULTS 
 Characteristics of the study subjects 
Study I 
The study population consisted of 6 035 participants (55% women) of the Health 
2000 Survey for whom the information on QUS measurements and vitamin D 
status was available (75% of the original sample). The mean age of men and 
women was 50.9 and 53.0 years, respectively. The mean values of BUA and SOS 
were 81.8 dB/MHz and 1556 m/s in men and 75.1 dB/MHz and 1550 m/s in 
women, respectively. Vitamin D status was similar in men and women (45.1 in 
men vs. 45.2 nmol/l in women). Half of the women were postmenopausal. 
Characteristics of the study population are shown in detail in Study I, Table 1. 
 
Study II 
The study population consisted of 2 028 women aged 45 years or over at baseline 
who had participated in the Mini-Finland Health Survey and for whom the 
information on parity and age at the last menstrual period was available (80% of 
the participating women aged 45 years or over). The mean age of women at 
baseline was 63.2 years. The mean S-25(OH)D concentration was 38.3 nmol/l. 
The number of women who had never given birth (nulliparous) was 395. The 
number of women with one to two births was 737, and 881 women had at least 
three births. During a mean follow-up of 13 years (26 200 person-years), 133 of 
the women sustained their first hip fracture at the mean age of 79.7 years.  
 
Study III 
Subjects aged 50 years or over at baseline for whom information on QUS 
measurement was available formed the study population of study III. After the 
exclusion of victims of high-energy-based hip fractures (n=20), the study 
population consisted of 3 305 subjects (75% of those within this age range in the 
original sample) of which 57 percent were women. The mean age of subjects at 
baseline was 62.9 years. The mean values of BUA, SOS and QUI were 76.2 
dB/MHz, 1546 m/s and 93.9, respectively. The mean S-25(OH)D concentration 
was 46.8 nmol/l. Characteristics of the study population are shown in detail in 
Study III, Table 1. During a mean follow-up of 8.4 years (27 757 person-years) 
95 of the subjects sustained a hip fracture at the mean age of 79.4 years. Of these, 
89 were considered first hip fractures.  
 
Study IV 
Subjects aged 55 years or over at baseline who participated in the health 
examination and for whom information on walking speed, handgrip strength, QUS 
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measurement and S-25(OH)D was available formed the study population of study 
IV. After the exclusion of all subjects with previous hip fracture (n=19) and those 
with emerging high-energy-based hip fractures (n=9) the study population 
consisted of 2 300 subjects (80% of those aged 55 or over in the original sample) 
of which 58% were women. The mean age of subjects at baseline was 66.4 years. 
The mean value of QUI was 93.1 and the mean S-25(OH)D concentration 47.6 
nmol/l. Handgrip strength among study population was on average 315.1 N. The 
mean value of maximal walking speed was 1.5 m/s. The prevalence of Parkinson’s 
disease was 0.45 percent, and 7.7 percent of subjects had suffered from stroke. 
Almost three-quarters of subjects suffered from hypertension, and almost 10 
percent were diabetics. The baseline characteristics of the study population are 
shown in Table 1 of Study IV. During the mean follow-up of 9.8 years (22 540 
person-years), 96 (3.6%) of the subjects sustained a first hip fracture at the mean 
age of 80.7 years. Fracture of the femoral neck was the most common type of hip 
fracture representing 65 percent of all first hip fractures. 
 Determinants of QUS (Study I) 
Higher age was associated with lower values of SOS and BUA in women. S-
25(OH)D and height correlated positively with both QUS variables, and weight, 
BMI and fat mass were positively associated with BUA. On the other hand, BMI, 
fat percentage and fat mass correlated negatively with SOS in women.  
Higher concentrations of S-25(OH)D were associated with significantly higher 
values of SOS and BUA  also in multiple linear regression modelling including 
all significant bivariate correlates of QUS variables as covariates (Study I, Table 
3). These associations appeared to be linear over the S-25(OH)D distribution (7-
134 nmol/l) (p values of the squared term of S-25(OH)D in the adjusted models 
were non-significant). Mean values of SOS adjusted for age, height, weight and 
lifestyle factors were 1550 and 1554 m/s in the lowest and in the highest quintiles 
of S-25(OH)D, respectively. Corresponding figures for BUA were 74.1 and 77.2 
dB/MHz. Other significant and independent determinants of BUA and SOS in 
women were age, height and postmenopausal status, all of which were negatively 
associated with the QUS variables. Weight was an independent determinant of 
BUA. The studied lifestyle factors, alcohol consumption, smoking and physical 
activity, were also significant and independent determinants of the QUS variables, 
except smoking and physical activity for BUA. In postmenopausal women 
analysed separately, S-25(OH)D, weight and years on HRT showed an 
independent positive contribution to both SOS and BUA. Age and smoking, on 
the other hand, were negative determinants of both QUS variables studied.  
In men, age was negatively associated with SOS. S-25(OH)D, weight and BMI 
were significant positive correlates of BUA and SOS, whereas height, fat 
percentage and fat correlated positively with BUA. 
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According to the results of a multiple linear regression model, S-25(OH)D was 
significantly associated with SOS and BUA in men, when all other significant 
bivariate correlates of QUS variables were adjusted for. Similarly to women, this 
association appeared to be linear over the S-25(OH)D distribution (5-134 nmol/l) 
also in men. The adjusted mean values of SOS were 1551 and 1560 m/s in the 
lowest and in the highest quintile of S-25(OH)D, respectively. Corresponding 
values in BUA were 80.0 and 83.4 dB/MHz. Other independent and significant 
determinants of QUS variables were age and height and these were negatively 
associated with SOS and weight, which was positively associated with both SOS 
and BUA. Alcohol consumption, smoking and physical activity were significant 
and independent determinants of both QUS variables in men. 
 Risk factors of hip fracture (Studies II-IV) 
Studies II-IV assessed age, gender, anthropometry, parity, QUI, S-25(OH)D, 
walking speed, handgrip strength, lifestyle factors, number of falls, chronic 
conditions and medication for their prediction for hip fracture. Table 4 
summarizes independent risk factors for hip fracture according to the studies. 
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 Independent risk factors for hip fracture (x-marked) according to 
studies II-IV.  
Variables Study IIa Study IIIb Study IVc 
Age x x x 
Gender  x  
Weight  x  
Height  x x 
Waist circumference   x 
S-25(OH)D x x  
Smoking x   
Alcohol consumption x   
Physical activity x   
Parity x   
QUI  x x 
Walking speed   x 
Parkinson’s disease   x 
CNS active medication   x 
a Adjusted for the variables in the column (x-marked) and for BMI, age at the last menstrual period, 
level of education and self-rated health 
b Adjusted for the variables in the column (x-marked) 
c Adjusted for the variables in the column (x-marked) and for gender and handgrip strength 
 
 
 
Age and gender (Studies II-IV) 
Increasing age was a strong independent predictor of hip fracture in all follow-up 
studies. In Study II, including women aged 45 years or over at the baseline, one 
SD increment in age (9.2 years) was associated with over a threefold increase in 
hip fracture risk when adjusted for BMI, reproductive factors, vitamin D status, 
lifestyle factors, level of education and self-rated health (Study II, Table III). 
Similarly in Study III including both men and women, aged 50 years or older, one 
SD increase in age (9.8 years) was associated with a 3.5-fold risk of hip fracture 
(Study III, Table 3). Also in Study IV, including men and women aged 55 years 
or older, one SD increase in age (8.2 years) was associated with over a two-fold 
risk of hip fracture (Study IV, Table 3). 
Age was a significant predictor of hip fracture also in a separate analysis 
among subjects aged 75 years or over (n=528, Study IV). According to this 
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analysis one SD increase in age (3.6 years) was associated with almost a 1.5-fold 
risk of hip fracture when gender was taken into account (HR=1.44, 95% CI=1.18-
1.76). 
Female gender appeared to be significantly and independently associated with 
hip fracture risk in Study III (HR=2.39, 95% CI=1.15-4.96) after adjusting for 
age, height, weight, S-25(OH)D and QUI. However, no significant association 
between gender and hip fracture risk was found in Study IV, either in the age-
adjusted model or in the model further adjusted for height, waist circumference, 
QUI, handgrip strength, walking speed, Parkinson’s disease and number of CNS 
active medication (Study IV, Table 3). 
 
QUS (Studies III and IV) 
Bone strength was assessed by means of calcaneal quantitative ultrasound. On the 
basis of measured BUA and SOS values, QUI was estimated. This was used in the 
final risk assessment models. Adjusted for gender, age, height, weight and S-
25(OH)D, one SD increment in QUI (21.7) was associated with a 40 percent lower 
risk of hip fracture in Study III (Table 3). Conversely, a decrease of one SD in 
QUI was associated with a 67 percent increase in risk (HR=1.67, 95% CI=1.16-
2.34). Similarly, one SD increment in BUA (19.5 dB/MHz) was associated with 
a 38 percent lower risk (95% CI=0.46-0.84) and one SD increment in SOS (35.3 
m/s) was associated with a 39 percent lower risk (95% CI=0.42-0.87) for hip 
fracture. In Study IV, with the follow-up time extending up to 11 years, QUI was 
also a significant predictor of hip fracture. Adjusted for gender, age, height, waist 
circumference and fall-related factors, such as walking speed, handgrip strength, 
number of CNS active medication and Parkinson’s disease, one SD increment in 
QUI (21.7) was associated with a 28 percent lower risk for subsequent hip fracture 
(HR=0.72, 95% CI= 0.53-0.98).  
The quintiles of QUI were further examined to assess if there would be a 
certain cut-off value with respect to hip fracture risk. Adjusted for gender, age, 
height and weight, QUI values of less than 74.3 appeared to be associated with a 
doubled risk for hip fracture (HR=2.14, 95% CI=1.21-3.78) compared to values 
greater than or equal to 74.3 (Study III). QUI did not quite reach statistical 
significance in the age and gender adjusted analysis (HR=0.74, 95% CI=0.53-
1.01) performed among subjects aged 75 years or over (Study IV). However, the 
cumulative hazards of hip fracture, adjusted for gender, height and waist 
circumference, showed a substantial divergence between the quintiles of QUI after 
this age (Study IV, Figure 1 a). Yet, when the hazards were further adjusted for 
fall-related factors (maximal walking speed, Parkinson’s disease and the number 
of prescribed CNS active medication), they were markedly smaller and less 
divergent between the quintiles (Study IV, Figure 1 b). 
 
 
 
Results 
 
55 
 
S-25(OH)D (Studies II-IV) 
S-25(OH)D was an independent and significant predictor of hip fracture in Studies 
II and III. In Study II, one SD increment in S-25(OH)D (18.3 nmol/l) adjusted for 
age, BMI, reproductive factors, lifestyle factors, education and self-rated health, 
was associated with a 21 percent lower risk of hip fracture (RR=0.79, 95% 
CI=0.64-0.98) among postmenopausal women. In Study III, including both men 
and women aged 50 years or over, one SD increment in S-25(OH)D (17.5 nmol/l) 
was associated with a 31 percent lower risk (HR=0.69, 95% CI=0.55-0.87) when 
adjusted for gender, age, height, weight and QUI. According to the analysis of 
quintiles of S-25(OH)D, the values less than 60.0 nmol/l indicated a significantly 
higher risk of hip fracture (HR=2.53, 95% CI=1.17-5.46) compared to values 
greater than or equal to 60.0 nmol/l (Study III). In Study IV, S-25(OH)D did not 
quite reach statistical significance in the model adjusted for age and gender 
(HR=0.85, 95% CI=0.70-1.03). 
 
Anthropometry (Studies II-IV) 
Higher body weight was associated with a lower risk of hip fracture in Study III 
when adjusted for gender, age, height, S-25(OH)D and QUI (HR=0.73, 95% 
CI=0.54-0.99). However, in Studies II and IV BMI or weight did not quite reach 
statistical significance (Study II, Table 3; Study IV, Table 3). On the other hand, 
waist circumference appeared to be an independent predictor of hip fracture in 
Study IV. One SD increment in waist circumference (12.4 cm) was associated 
with a 29 percent lower risk for hip fracture (HR=0.71, 95% CI=0.55-0.92). 
Tall stature was a risk factor of subsequent hip fracture. In Study III, the risk 
was increased by 82 percent per 9.5 cm increment in height (HR=1.82, 95% 
CI=1.43-2.32) when adjusted for gender, age, weight, S-25(OH)D and QUI. 
Similarly, in Study IV an increment of 9.4 cm in height was associated with 74 
percent higher risk of subsequent hip fracture (HR=1.74, 95% CI=1.23-2.46) in 
the model adjusted for gender, age, waist circumference, QUI and fall-related 
factors such as, handgrip strength, walking speed, Parkinson’s disease and number 
of CNS active medication. 
 
Smoking, alcohol consumption and physical activity (Studies II-IV) 
In Study II, smoking, alcohol consumption and physical activity were 
significantly associated with hip fracture risk (Study II, Table 3). Current smoking 
of at least 20 cigarettes a day was especially harmful (RR=9.26, 95% CI=3.85-
22.25). Alcohol consumption of at least 249 g of ethanol/week was associated 
with almost fivefold higher risk of hip fracture compared to those not using 
alcohol (RR=4.78, 95% CI=1.02-22.38). Those women who were moderately 
physically active had 36 percent lower risk of fracture (RR=0.64, 95% CI=0.42-
0.97) compared to sedentary women. In Studies III and IV, none of the studied 
lifestyle factors were significant predictors of hip fracture (Study III, Table 3; 
Study IV, Table 3). 
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Handgrip strength and walking speed (Study IV) 
Handgrip strength and maximal walking speed were examined for their prediction 
of hip fractures in Study IV. Both of these variables differed between subjects 
with and without an incident hip fracture (p values of <0.0001 for both). Also, in 
the gender- and age-adjusted models, a one SD increase in both handgrip strength 
(121.8 N) and maximal walking speed (0.40 m/s) was significantly associated with 
hip fracture risk (Study IV, Table 3). However, when further adjustments were 
made for height, waist circumference, QUI, Parkinson’s disease, number of CNS 
active medications and each other, only maximal walking speed proved to be an 
independent and significant predictor of hip fracture. According to this model, one 
SD increase in walking speed (0.40 m/s) was associated with a 30 percent lower 
risk of hip fracture (HR=0.70, 95% CI=0.54-0.92).  
 
Chronic conditions (Study IV) 
Contribution of chronic conditions, such as Parkinson’s disease, stroke, 
hypertension, and diabetes, to hip fracture risk was assessed in Study IV. Of these, 
only Parkinson’s disease appeared to have an independent and significant 
association with hip fracture risk. Subjects with Parkinson’s disease had a 
sevenfold risk of hip fracture compared to those free of this disease (HR=7.08, 
95% CI=2.19-22.93) when adjusted for gender, age, height, waist circumference, 
QUI, handgrip strength, walking speed and number of CNS active medication. 
 
CNS active medication and liability to fall (Study IV) 
The number of prescribed CNS active medication (opioids, anticonvulsants, 
antipsychotics, anxiolytics, hypnotics and sedatives, antidepressants or 
psycholeptics and psychoanaleptics in combination) differed between subjects 
with and without an incident hip fracture (p=0.03) (Study IV, Table 2). According 
to the model that included gender and other significant predictors, such as age, 
height, waist circumference, QUI, handgrip strength, walking speed and 
Parkinson’s disease, subjects using three or more CNS active medications had 
almost a threefold risk of hip fracture (HR=2.82, 95% CI=1.03-7.77) compared to 
those who did not use such medication. 
There was a tendency towards increased risk of hip fracture along with 
increasing degree of faintness or dizziness as recent symptoms. Also, a higher 
number of falls during the previous 12 months tended to be associated with 
increased hip fracture risk. However, these associations did not reach statistical 
significance in gender- and age-adjusted models (Study IV, Table 3). 
 
Parity (Study II) 
Study II assessed parity for its prediction of hip fracture in postmenopausal 
women over a mean follow-up of 13 years. Adjusted for age, parity showed an 
inverse association with hip fracture risk (RR=0.74, 95% CI=0.61-0.90) per 
increment of one SD (2.4 births). This association appeared, however, to diverge 
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from linearity and thereby parity was classified into three categories: nulliparous, 
parous with 1-2 births and parous with three or more births. Adjusted for age, 
BMI, age at the last menstrual period, S-25(OH)D, smoking, alcohol 
consumption, physical activity, education and self-rated health the risk of hip 
fracture were significantly lower in women with three or more births (RR=0.50, 
95% CI=0.32-0.79) compared to nulliparous women. The risk tended to be lower 
also among women with one to two births compared to nulliparous women 
although the difference was not statistically significant (RR=0.85, 95% CI=0.55-
1.32). 
A statistically significant interaction was found between parity and age at the 
last menstrual period (p=0.03). Only those women with three or more births and 
who were more than 50 years of age at their last menstrual period had a 
significantly decreased risk for hip fracture compared to nulliparous women. The 
same did not hold true among women with three or more births who were 50 years 
or younger on that occasion (Study II, Table 4). 
 Multivariate prediction of hip fracture (Studies III and 
IV) 
The predictive power of models with various combinations of risk factors was 
assessed by means of coefficients of determination (R²). In Study III, R² indicated 
that age alone explained 66 percent of the variation in the observed hip fracture 
risk. When gender, height and weight were added to the model, R² increased to 72 
percent. The addition of QUI improved this figure by four percentage units (a 6% 
relative increase) and the addition of S-25(OH)D by three percentage units (a 4% 
relative increase) (Study III, Table 4). The model, including all of these variables, 
explained 78 percent of the variation in hip fracture risk. 
According to the results of separate analyses in Study III on subjects 75 years 
or over performed, absolute R² values were clearly lower compared to younger 
subjects. The model, including age, gender, height and weight explained 10 
percent of the variation in the observed hip fracture risk. Adding QUI or S-
25(OH)D to this model improved the coefficient of determination by seven 
percentage units (a 70% relative increase). The addition of both of these improved 
the predictive power of this model by 13 percentage units (130% relative 
increase). 
In Study IV, including men and women aged 55 years or over, the model that 
included age, gender, height and waist circumference explained 59 percent of the 
variation in the observed hip fracture risk. This figure was improved by an 
increment of four percentage units (a 7% relative increase) when walking speed 
was added to the model. Adding QUI to the model improved its predictive power 
by 3 percentage units (a 5% relative increase). The model, including all of these 
variables added by Parkinson’s disease and CNS active medication, explained 
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68% of the variation in hip fracture risk. Without QUI the predictive power of this 
model was 66% (Study IV, Table 4). 
The additional analyses of net reclassification improvement (NRI) performed 
using a three percent risk threshold showed a significantly improved performance 
of the model, which included age, gender, height and waist circumference when 
either Parkinson’s disease (NRI=3.3%, p=0.04), use of CNS active medication 
(NRI=6.0%, p=0.01) or QUI (NRI=6.4%, p=0.03) was added. No significant 
change was found in NRI when walking speed was separately added to that model 
(NRI=3.4%, p=0.15). However, walking speed along with Parkinson’s disease 
and CNS active medication significantly improved the discriminative ability of 
the same model (NRI=8.4%, p=0.01). Further addition of QUI into that model 
including all other significant predictors resulted in no significant improvement 
(NRI=0.4%, p=0.84). 
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6 DISCUSSION 
 Determinants of QUS (Study I) 
In this thesis bone strength was assessed by means of a calcaneal QUS 
measurement performed with the Hologic Sahara device (Hologic, Bedford, MA, 
USA). No previous study has identified determinants of calcaneal QUS in a 
representative Finnish adult population sample. Here, several risk factors of bone 
fragility previously found to be associated with BMD, assessed by means of DXA, 
were also found to be determinants of calcaneal QUS.  
QUS values in men and women were inversely associated with age. This is in 
accordance with a number of previous studies that show a decreased level of BMD 
and QUS along with increasing age [272-277]. These changes appeared to be 
linear in men. In women, the slope was steeper after the age of about 50 years. 
This is not unexpected because the decline in ovarian function and the resultant 
decrease in estrogen levels are likely to affect bone strength in the postmenopausal 
phase [17,277-280]. This finding is also reflected in the negative association found 
between postmenopausal status and QUS variables. 
Vitamin D status was a significant and independent determinant of SOS and 
BUA in both men and women. This finding is in accordance with previous studies 
that show the importance of adequate vitamin D status for bone health [281-283]. 
There is no consensus on what would be the optimal S-25(OH)D concentration. 
Based on S-25(OH)D concentrations at which measured PTH levels begin to level 
off [169,170], concentrations between 50 and 80 nmol/l have been considered 
sufficient for bone health [167,168]. In the present study, no specific threshold 
value was found. Instead, the associations with SOS and BUA appeared to be 
rather linear over the entire S-25(OH)D distribution. 
We found an inverse association between fat mass and S-25(OH)D in spite of 
higher intakes of vitamin D in those with higher body fat mass (Study I, Figure 
1). This agrees with previous case-control and population-based studies [284-
287]. More recent studies have similarly found decreased S-25(OH)D levels in 
obese subjects [288,289]. These findings may be explained by a decreased 
bioavailability of vitamin D due to increased storage in the adipose tissue, 
sedentary lifestyle and genetic changes in vitamin D metabolism in obese subjects 
[286,289,290]. 
The positive association between weight and QUS variables was an expected 
finding in agreement with several previous studies that showed higher QUS or 
BMD values in heavier subjects [276,277,291,292]. The association between 
height and QUS values was found to be negative in the multiple linear regression 
model adjusted for age, weight, S-25(OH)D and lifestyle factors. This finding is 
contradictory to that of Welch et al. [277] who found a positive association 
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between height and BUA. The discrepant result in the present study might result 
from fairly slender bones in tall subjects. The studied lifestyle factors, physical 
activity, smoking and alcohol consumption appeared to be significant 
determinants of QUS variables with the exception of smoking and physical 
activity for BUA in women. Previous cross-sectional studies have found that 
physical activity is positively associated with QUS variables in both genders, 
whereas the associations between smoking or alcohol use and QUS have been less 
consistent [275,276,278,293-295]. Several previous studies have established a 
negative association between smoking and BMD [296-298]. The non-significant 
association between smoking and BUA in women probably resulted from the 
small number of smokers among them.  
 Risk factors of hip fracture (Studies II-IV) 
Bone strength-related factors 
Several prospective studies show that calcaneal QUS variables measured by 
means of various devices can predict hip fractures in elderly men and women 
[30,72,73,144,159-161]. Likewise, in the present study, QUS was a significant 
predictor of hip fracture even when adjusted for multiple potential predictors of 
hip fracture, such as S-25(OH)D, lifestyle factors, comorbidity and fall-related 
risk factors (III, IV). The hazard ratio of 1.67 per one SD decrease in QUI was 
comparable to a gradient of risk of 1.99 for the QUI reported in a recent meta-
analysis [30]. However, there is a considerable heterogeneity existing among 
studies for the association of QUS variables and hip fracture risk, largely due to 
technological differences between the different devices [64]. Only one 
prospective study, thus far, has assessed different QUS devices for hip fracture 
prediction in an elderly population [264]. According to the results of that study, 
two calcaneal QUS devices (Achilles+ and Sahara) showed a similar hip fracture 
prediction in all assessed variables (BUA, SOS, QUI/SI). Obviously, more 
information is needed to guage the performance of different QUS devices 
concerning fracture risk prediction. In addition, methods for standardization or 
cross-calibration among brands of QUS devices should be developed.  
The results presented here showed a higher risk of hip fracture in subjects with 
QUI values below 74.3 (III). This value was higher compared to the results of a 
previous study based on a large dataset from three case-control studies in which 
the threshold of QUI measured with Sahara device was at 63.2 [299]. The 
differences in these threshold values may be partly explained by differences in the 
age-range and designs of the studies. The study population of the present study 
(III) included both men and women aged 50 years or over while that of Hans et 
al. [299] included only women aged 65 years or over. 
In a separate analysis of a subpopulation aged 75 years or older (IV), QUI did 
not quite reach statistical significance (HR=0.74, 95% CI=0.53-1.01) for an 
Discussion 
 
61 
 
association with hip fracture risk. Previous studies assessing BMD measured by 
means of DXA for prediction of fractures have similarly found smaller risk 
gradients along with an increasing age [56,300,301]. Here, an increasing 
divergence in cumulative hazards of hip fracture adjusted for gender, height and 
waist circumference was seen between the quintiles of QUI after the age of 75 
years (Study IV, Figure 1 a). After further adjustment for fall-related factors, such 
as walking speed, Parkinson’s disease, and CNS active medication the hazards 
diminished and became less divergent (Study IV, Figure1 b). This is likely to 
indicate a gradual shift of focus in hip fracture prediction from bone strength to 
fall risk related factors in the oldest subjects.  
In agreement with the results of several previous prospective studies [89-93], 
a higher weight was associated with a decreased risk for hip fracture in this study 
(III). Higher weight is associated with higher skeletal load, which is likely to 
increase bone strength. Also, higher fat mass and a longer waist circumference, a 
surrogate marker for abdominal fat [302], were associated with lower hip fracture 
risk (IV). Adipose tissue becomes a major source of estrogen in postmenopausal 
women [303]. Therefore, a higher amount of adipose tissue may be associated 
with a higher amount of estrogen which in turn, affects bone turnover. In addition, 
a thicker adipose tissue layer has a protective effect in case of a fall. On the other 
hand, low BMI, weight loss in particular, may be an indicator of overall poor 
health which contribute to fracture risk. However, the association between obesity 
and fracture risk is not unambiguous. It has been suggested that neuromuscular 
performance rather than body mass is an explanatory factor of bone strength [304]. 
Also, several studies have found that a substantial proportion of osteoporotic 
fractures, including hip fractures, occurs in obese postmenopausal women and 
older men [95]. Moreover, it has been suggested that obesity is a risk factor for 
some fractures, such as ankle and humeral fractures, but protective against some 
fractures, such as hip fracture [95]. 
In agreement with the results of several previous studies [19,23,92,96], tallness 
was a significant predictor of hip fracture in this study. Suggested mechanisms by 
which tallness affects hip fracture risk include a greater impact in falling as well 
as geometrical characteristics of the femoral neck that affects bone strength 
[23,97,98]. 
Previous studies have shown adverse effects of active smoking with respect to 
hip fracture risk [91,92,110,111]. In the present study heavy smoking (≥20 
cigarettes/day) was significantly associated with increased risk of hip fracture 
among postmenopausal women aged 45 years or over (II). However, in Studies 
III and IV, including both men and women aged 50 years or over, smoking did 
not reach statistical significance. In these studies smoking was classified into 
categories of never-smokers, former smokers and current smokers and the impact 
of heavy smoking may have not been captured. On the other hand, the number of 
heavy smokers is likely to be low, especially among elderly women. 
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Similarly to several previous studies [124,125] a lower risk of hip fracture was 
found along with increasing parity. Compared to nulliparous women the risk was 
significantly lower among women who had given three or more births (II). Among 
these women, the risk was lowest in women who were older than 50 years at their 
last menstrual period. These findings are likely to reflect the beneficial effects of 
long-term estrogen exposure on bone health and fracture risk [121]. 
 
Fall-related factors (IV) 
Maximal walking speed was a significant and independent predictor of incident 
hip fracture in the present study (IV). This agrees with the results of previous 
prospective studies using elderly men and women cohorts [24,128,134,135]. 
Walking is a complex motor skill and the automaticity of which is likely to 
diminish along with increasing age [305]. Walking speed is, in older subjects, a 
useful indicator of muscle strength, balance and other sensorimotor functions 
[138,139], which will ultimately affect fall risk and subsequent risk of fracture. 
Here, maximal walking speed of around 1.5 m/s was optimal for hip fracture 
prediction. This is clearly higher than the threshold value of 1.0 m/s used in 
previous studies assessing walking speed for the prediction of several adverse 
health outcomes [147]. This difference may be at least partly explained by actually 
different outcomes in these studies. Nevertheless, the population of the current 
study was younger than those in previous studies. In addition, previous studies 
mostly assessed habitual walking speed, whereas the present study dealt with 
maximal walking speed.  
Other significant fall-related risk factors in this study were Parkinson’s disease 
and use of CNS active medication. These findings are in accordance with those of 
previous studies [23,85,128,149,150,154,155]. In the present study, over a 
sevenfold risk of hip fracture was found in subjects with Parkinson’s disease 
compared to those free from this disease. However, the number of patients with 
Parkinson’s disease was small (n=11) and the results should therefore be 
interpreted with caution.  
Elderly subjects are prone to suffer from adverse effects of medication. This is 
related to physiological changes, which along with increasing age, affect 
absorption, distribution, metabolism and excretion of medicines. In addition, 
polypharmacy is more common in old age. Both, the total number and certain 
specific medications increases the risk of falls [151].  Here, subjects who used at 
least three prescribed CNS active medicines (such as opioids, anticonvulsants, 
anxiolytics, hypnotics, and sedatives, antidepressants and psycholeptics) had an 
increased risk of hip fracture compared to those who were not receiving such 
medication.   
 
Multifactorial risk factors (II,III,IV) 
An older age is a well-established risk factor for hip fracture. Old age is associated 
with decreased bone strength, but predicts hip fractures even independently of 
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BMD [6,9]. It appears that later in life factors associated with functional capacity 
gain more significance with respect to hip fracture prediction. In the present study, 
age was a significant and independent predictor of hip fracture even when adjusted 
for QUI and fall-related risk factors, such as walking speed, Parkinson’s disease 
and CNS active medication (IV).  
Elderly women are especially prone to hip fracture because they have generally 
lower peak bone mass and smaller bones compared to men, and because their 
estrogen deficiency causes a rapid lose of bone mass after menopause [17]. Here, 
women had over twice the risk of hip fracture compared to men when adjusted for 
age, body build, S-25(OH)D and QUI.  
Similarly to some earlier prospective studies [173,174,179], S-25(OH)D was 
also in the present study an independent and significant predictor of hip fracture 
in men and women (II, III). According to the analysis of quintiles of S-25(OH)D  
values  of less than 60.0 nmol/l indicated a significantly higher risk for hip fracture 
(HR=2.53, 95% CI=1.17-5.46) compared to values greater than or equal to 60.0 
nmol/l (III). This is comparable to S-25(OH)D levels that range between 50 and 
80 nmol/l, which were previously considered optimal for bone health [167,168]. 
On the other hand, S-25(OH)D did not quite reach statistical significance in the 
age- and gender-adjusted model (HR=0.85, 95% CI=0.70-1.03) in Study IV with 
somewhat longer follow-up period compared to Study III. Because S-25(OH)D 
was measured only at baseline, the changes in vitamin D status during the follow-
up of Study IV were more likely than in Study III, which may diminish its 
association with fracture risk.  
Previous studies have shown contradictory results on the association between 
vitamin D supplementation and fracture risk. Randomized controlled trials have 
often found no significant difference in BMD or hip fracture risk between subjects 
randomized to receive vitamin D supplementation and subjects in the control 
group [172,177]. On the other hand, observational studies have commonly shown 
significantly lower S-25(OH)D levels among subjects with hip fracture compared 
to controls [172]. Reasons for these contradictory results are not known. However, 
it is possible that the lack of a statistically significant association between vitamin 
D supplementation and fracture risk in RCTs has been related to insufficient 
statistical power because of too short follow-up times, inadequate number of 
recorded fractures, inappropriate vitamin doses or because the intervention has 
been targeted to a population that was not deficient in vitamin D [172,181]. On 
the other hand, it is likely that vitamin D supplementation would have been more 
efficient if combined with calcium [105,178,180]. Moreover, observational 
studies may suffer from uncontrolled confounding, such as physical activity with 
exposure to sunlight, comorbidity and frailty, which all  mask an association 
[172].  
Here (I), moderate hypovitaminosis or vitamin D deficiency (S-25(OH)D<37.5 
nmol/l) was found in almost half of the study population aged 30 years or over 
studied during years 2000 and 2001. Comparable results have been found in a 
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more recent study that assessed vitamin D status in Finnish subjects aged 45 to 74 
years in 2007 [306]. In order to ensure an adequate vitamin D status in the Finnish 
population, the recommended level of vitamin D intake has been recently raised 
in the updated Finnish Nutrition Recommendation [307] up to 10 µg (400 IU) per 
day for adults and children aged two years or older and 20 µg (800 IU) per day 
for subjects aged 75 years or older. There is an ongoing debate on what would be 
an optimal S-25(OH)D level with respect to skeletal and extra-skeletal health, and 
disagreement persists regarding the recommendations of vitamin D intake. For 
example, the US IOM (Institute of Medicine) recommends vitamin D doses of 20 
µg (800 IU) in older adults (>70 years) in order to achieve S-25(OH)D levels of 
50 nmol/l [308]. On the other hand, the US Endocrine society proposes daily doses 
of at least 38 to 50 µg (1500-2000 IU) in the same age group in order to achieve 
a target level of 75 nmol/l, and even higher intakes in some cases of vitamin D 
deficiency [309]. However, high doses of vitamin D may not be beneficial with 
respect to bone health and fall risk, and may even have adverse effects on bone 
health [181,310,311]. Adverse effects have been found to occur especially along 
with extremely high intermittently administered doses. Based on the results of 
these and other previous RCTs and observational studies [312], it may not be 
advisable to recommend high S-25(OH)D concentrations for the entire 
population. Rather, it is essential to identify subjects who are most likely to be 
vitamin D deficient (e.g., elderly subjects, institutionalized or homebound and 
subjects with malabsorption) and target the interventions of vitamin D 
supplementation, accordingly. In these cases, monitoring of serum 25(OH)D may 
be required. 
An additional challenge with respect to determination and monitoring an 
optimal S-25(OH)D level is brought by the fact that results of S-25(OH)D 
measurements performed with different assays in different laboratories are not 
comparable [313-315]. Previous studies show that the capability of different 
assays to discriminate between low, moderate and high values is relatively good 
[314]. However, the definition of vitamin D status in absolute terms may be more 
complicated without standardization and careful cross-calibration between the 
values from different laboratories. This should be taken into account when 
comparing the results of different studies from different laboratories.  
Previous studies have shown an inverse association between physical activity 
and hip fracture risk in men and women [92,111,192-195]. In the present study, a 
tendency towards higher risk was observed in sedentary subjects (II, III, IV). 
However, in the models adjusted for age and gender, physical activity did not quite 
reach statistical significance. 
Previous fragility fracture is a significant predictor of future hip fracture 
[22,128,159,160,242,243]. Here, previous hip fracture did not show a significant 
contribution to hip fracture risk among men and women aged 50 years or older 
(III). This is likely to be related to the lack of statistical power since the proportion 
of subjects with previous fragility fracture was low (0.8%).  
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Socio-economic status has been suggested to contribute to hip fracture risk, 
even independently of known risk factors of osteoporosis [222,316,317]. In the 
present study (II), socio-economic status assessed by means of the level of 
education was not independently associated with hip fracture risk. This may partly 
be related to low number of those with high education (>12 years of education), 
but also to that other, more proximal risk factors of hip fracture, such as lifestyle 
may have explained the association [318]. 
 Multivariate prediction of hip fracture (Studies III and 
IV) 
A large number of risk factors for hip fracture have been identified, and the current 
challenge is to develop practical methods that could accurately identify subjects 
who are at an increased risk. Old age is a well-known powerful predictor of hip 
fracture. Identifying factors that significantly contribute to fracture risk along and 
beyond age is important. Here, age explained up to 66 percent of the variation in 
the fracture risk (III). The additions of QUI and S-25(OH)D or QUI and the fall-
related risk factors (maximal walking speed, Parkinson’s disease and number of 
prescribed CNS active medicines) clearly increased the predictive power of the 
model, which included age, gender and measures of body build (III, IV). This 
agrees with the results of previous prospective studies that show that combining 
bone strength-related factors with fall-related factors improves the prediction of 
hip fracture [24,144,159,160]. In the present study, improvements in the 
predictive power of the model that included age, gender, height and waist 
circumference were similar after the addition of QUI, walking speed, Parkinson’s 
disease or CNS active medication. On the other hand, when QUI was added to the 
model that included age, gender, height, waist circumference and the fall-related 
factors only minor further improvement in the predictive power was seen. No 
significant improvement in discriminative ability (NRI) of the model was seen 
after this addition (IV). This finding suggests that a simple model including age, 
gender and measures of body built combined with the fall-related factors is at least 
as efficient in hip fracture prediction as a more complex model with measured 
bone strength-related factors. This parallels previous views that being prone to fall 
rather than bone fragility would be the principal determinant of fracture [248,319]. 
Recently, guidelines by WHO and IOF [25] have proposed a targeted approach 
in which assessment of future fracture risk would be based on 10-year probability 
of fracture. Based on this, fracture risk prediction tools, such as FRAX, QFracture 
and Garvan Fracture Risk Calculator have been developed [26,245,246]. FRAX 
has been recommended to be used for the assessment of fracture risk in clinical 
practice in many countries, including Finland [320]. However, information about 
the applicability of FRAX in the general Finnish population is lacking. In addition, 
no information is available about the threshold value of FRAX on which the 
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treatment would become cost-effective in Finland. One recent study assessed the 
calibration of the Finnish FRAX model in the OSTPRE (the Kuopio Osteoporosis 
Risk Factor and Prevention) study, a population-based cohort study of 
postmenopausal women from the Kuopio region of Finland [321]. In that study, 
the relationship between the FRAX probability of hip fracture and the 10-year 
period prevalence was examined by quintiles of fracture probability. The 
goodness-of-fit across these quintiles and predictive performance of FRAX model 
were evaluated. The authors of that study concluded that the Finnish FRAX tool 
provided appropriate discrimination for hip fracture risk. However, there was a 
lack of fit for absolute probabilities. The expected numbers of hip fractures based 
on FRAX models were significantly higher than self-reported (observed/expected 
ratio 0.46; 95% CI 0.33-0.63) and tended to be larger than observed ones 
(observed/expected ratio 0.83; 95% CI 0.65-1.04). The difference was evident 
especially in the highest risk quintile. 
In the present study we performed analyses using the variables that were 
available to us to construct a model corresponding to the FRAX model as closely 
as possible. These variables included: gender, age, weight, height, current 
smoking, current use of systemic glucocorticoids, rheumatoid arthritis, insulin-
dependent diabetes, Crohn’s disease, colitis ulcerosa, and celiac disease, liver 
disease assessed by means of gamma-glutamyl transferase measurement, 
premature (<45 years) menopause in women and alcohol use of three or more 
units daily. No significant associations were observed between these variables and 
hip fracture risk in age- and gender-adjusted analyses (data not shown). This was 
not an unexpected finding because our study population was derived from a 
nationally representative population sample in which diseases associated with an 
increased risk of osteoporosis are rare compared with selected clinical study 
populations.  
One of the known limitations of the FRAX tool is that it does not include falls 
as a risk factor [249]. The incorporation of fall risk to FRAX model has been 
argued to be problematic because information on falls has been scarce in cohorts 
used to derive and validate FRAX. However, there is evidence that falls [322,323] 
and fall-related fractures [324] can be prevented by interventions. This supports 
the idea of including fall-related risk factors in the fracture risk assessment, 
suggested by some authors [325].  
In the present study the models for hip fracture risk prediction were derived 
from the representative population sample of Finnish men and women with a 
follow-up period extending up to 10 years. The predictive performance (R2) of the 
models based on a few readily available risk factors, such as age, gender, measures 
of body build, bone strength-related factors and fall-related factors, was closely 
comparable with those reported from a previous prospective study based on the 
QFracture data covering a wide variety of predictors [245,326]. In the present 
study, the models including all significant predictors derived from the study data 
explained 68 to 78 percent of the variation in the hip fracture risk. The validation 
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study of the QFracture tool, using the same statistical method has reported R2 
values around 70 percent. Applied to the same data, the FRAX algorithm 
explained approximately 55 percent of the variation in the hip fracture risk [245]. 
Obviously, such studies cannot be directly compared. However, the results of the 
present study suggests that a simple model including readily available variables 
may perform equally well in fracture risk prediction compared to more complex 
models. 
 Strengths and limitations  
The strength of the present study is that it was based on two nationally 
representative health surveys with an exceptionally high participating rate 
[260,261]. In the Health 2000 Survey, the essential information on health and 
functional capacity was obtained from more than 93 percent of the subjects, and 
79 percent of the original sample participated in the health examination proper. In 
the Mini-Finland Survey, 96 percent of the sample participated in the health 
interview, and 90 percent in the health examination. The information about 
incident hip fractures was drawn from the National Hospital Discharge register, 
which is a reliable source of information with a nationwide coverage. The 
coverage of this register with respect to hip fractures is reported to be 98 percent. 
Also, the accuracy and sensitivity of the registered hip fracture diagnoses have 
been shown to be good (98%) [82]. 
One limitation of the current study was that the risk factors in Studies II, III 
and IV were measured only at baseline, and no information on the later changes 
of these factors was available. During a follow-up period extending up to 13 years 
changes are plausible in lifestyles, physical performance, health status and 
medication (II). Moreover, subjects living in residential care units were not 
included in our study population because QUS measurements were not included 
in home health examination conducted on subjects not attending the health 
examination proper (5% of the original sample). However, this is likely to 
diminish rather than give rise to the observed associations. 
In Study II, parity was assessed for its prediction of hip fracture in 
postmenopausal women. In this context, it would have been useful to assess the 
role of lifetime estrogen exposure. However, no such information was at our 
disposal. Neither were we able to assess whether the association between parity 
and fracture risk was mediated by potential effects of parity on BMD. Moreover, 
we did not know whether nulliparity was intentional or due to a fertility problem. 
The predictive performance of the simple model constructed in the present 
study appeared to be fairly good. However, its performance may have been 
maximized because it was constructed and tested on the same data. In order to test 
the predictive power of the model, it should be evaluated in a separate adult 
population. 
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A major limitation of the present study was the small number of hip fracture 
cases. Thus, in the analyses concerning rare risk factors statistical power was 
obviously low. For the same reason the analyses could not be made separately on 
men and women.  
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7 CONCLUSIONS 
Older age, tallness, smoking and postmenopausal status in women were 
negatively associated with the QUS variables (SOS, BUA) whereas higher weight, 
higher concentration of S-25(OH)D and physical activity as well as years on HRT 
in postmenopausal women showed positive association with these variables. A 
lower level of alcohol consumption was associated with lower QUS values in 
women and with higher values of QUS in men. 
Age, height, weight, waist circumference, QUI, S-25(OH)D and fall-related 
risk factors, such as maximal walking speed, Parkinson’s disease and the number 
of prescribed CNS active medicines were independent predictors of hip fracture. 
In addition, nulliparity was significantly associated with hip fracture risk among 
postmenopausal women. Among subjects aged 75 years or over age, maximal 
walking speed and the use of three or more prescribed CNS active medicines were 
independent predictors of hip fracture.  
Old age was the strongest predictor of the hip fracture explaining up to 66 
percent of the variation in hip fracture risk. The additions of QUI, S-25(OH)D and 
the fall-related factors (maximal walking speed, Parkinson’s disease and number 
of prescribed CNS active medicines) increased the predictive power of the model 
including age, gender and measures of body built. On the other hand, when QUI 
was added to the model, which included age, gender, height, waist circumference 
and the fall-related factors, only a minor further improvement in predictive 
performance was noticed.  
The incremental value of QUI in the prediction of hip fracture risk was small. 
Moreover, because there are no established diagnostic threshold values for QUS, 
it cannot be used as a diagnostic method for osteoporosis. In addition, the issues 
concerning standardization and cross-calibration among different QUS devices 
are yet to be resolved. Therefore, calcaneal QUS examination cannot be 
recommended for the assessment of hip fracture risk in an unselected adult 
population. 
The assessment of fall-related risk factors for hip fracture prediction appears 
to be essential in elderly subjects, in particular among those aged 75 years or over. 
The liability to fall can be assessed by the measurement of maximal walking speed 
and evaluations of the central nervous system for chronic diseases and 
medications affecting mobility and postural balance. The results of the present 
study suggest that a maximal walking speed of around 1.5 m/s would be optimal 
for hip fracture prediction. This threshold differs clearly from 1.0 m/s that has 
been used in previous studies as a threshold of habitual walking speed for the 
prediction of adverse health outcomes. However, further studies in larger elderly 
study populations are needed in order to determine the threshold value of maximal 
walking speed for identifying subjects at increased risk of hip fracture. 
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Lower level of S-25(OH)D was associated with a higher hip fracture risk. The 
optimal level of S-25(OH)D appeared to be equal to or greater than 60.0 nmol/l. 
However, the role of vitamin D status in hip fracture risk prediction appeared to 
be modest. Measurements of vitamin D thus can not be recommended for the 
assessment of hip fracture risk in unselected adult populations.  
This study presents a simple multifactorial model for the assessment of hip 
fracture risk among Finnish adults aged 50 years or over. Prospective studies are 
needed to test this model in patient-based study populations. 
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